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Abstract  
 
Young adult mortality is very important in South Africa with the impact of Human 
Immunodeficiency Virus /Acquired Immune deficiency Syndrome (HIV/AIDS), Tuberculosis 
(TB), injuries and emerging non-communicable diseases (NCDs). Investigation of temporal 
trends for adult mortality associated with TB and HIV has often based on age, gender, period and 
birth cohort separately. The overall aim of this study was to estimate age effect across period and 
birth cohort; period effect across age and birth cohort; and birth cohort effect across age and 
period on TB and HIV-related mortality. Mortality data and mid population estimates were 
obtained from Statistics South Africa for the period 1997 to 2015. Observed HIV/AIDS deaths 
were adjusted for under-reporting while adjustments for the misclassification of AIDS deaths and 
the proportion of ill-defined natural causes were made. Three-year age, period and birth cohort 
intervals for 15-64 years, 1997-2015 and 1934-2000 respectively were used. Age-Period-Cohort 
(APC) analysis using the Poisson distribution was used to compute effects of age, period and 
cohort on mortality due to TB and HIV.A total of 5, 825,502 adult deaths from the period 1997 
to 2015, of which 910,731 (15.6%) were TB deaths while 252,101 (4.3%) were HIV deaths. A 
concave down association between TB mortality and period was observed while an upward trend 
was observed for HIV-related mortality. The estimated TB relative mortality showed a concave 
down association with age, a peak at 36-38 years was found. There was a concave down 
relationship between TB relative risk between 1997 and 2015. Findings showed a general 
downward trend between TB mortality and birth cohort, which 1934 cohort had higher rates of 
mortality. There was an inverse flatter U-shaped association between age and HIV-related 
mortality, where 30-32 years was more pronounced. An inverse U-shaped relationship between 
HIV-related mortality and period from 1997 to 2015 was estimated. An inverted V-shape 
relationship between birth cohort and HIV-related mortality was estimated. The study has found 
an inverse U-shaped association between TB-related mortality and age, period and general 
downward trend with birth cohort for deaths reported between 1997 and 2015.A concave down 
relationship between HIV-related mortality and age, period and inverted V-shaped with birth 
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cohort was found. The association between HIV-related mortality and period differs from the 
officially reported trend with adjustment, which shows an upward progression. Our findings are 
based on a slight advanced statistical model using Age-Period-Cohort.  Using APC analysis, we 
found a secular trend in TB and HIV-related mortality rates which could contribute certain clues 
in long-term planning, monitoring and evaluation. 
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CHAPTER 1: INTRODUCTION 
 
1.1 Background 
 
Crucial indicators of mortality including age-specific, gender-specific mortality rates, 
expectation of life from birth together with the leading causes of death are useful for public 
health planning, implementation of monitoring and evaluation, distribution of resources as 
well as making major and minor decisions about the population (WHO 2018). This 
information allow government, at both national and subnational level, to develop strategic 
plans to administer necessary resources in order to reduce burden of diseases among limited 
resources settings (STATSSA 2015, STATSSA 2014 and Bradshaw et.al 2012). The 
knowledge of young adult mortality is very important in South Africa to provide reliable 
population estimates and projections that underlie planning in any sectors, especially with an 
influence of Human Immunodeficiency Virus /Acquired Immune deficiency Syndrome 
(HIV/AIDS), Tuberculosis (TB), injuries and emerging non-communicable diseases. In order 
to produce health outcome rates, population statistics are needed at both national and 
subnational level. However, the availability of vital registrations is usually the limiting factor 
(STATSSA 2014 and Bradshaw et.al 2012). 
 
Mortality rates are often measured mathematically as the number of observed deaths over a 
studied population at a given period of time (Simpfendorfer, Bonfil, and Latour, 2005). These 
mortality rates are then determined using occurring death ratios during specified period of 
time to overall exposed population (persons-years) among which deaths occurred. In most 
cases, these mortality rates are multiplied by 1000, 10 000 or 100 000 depending on the 
frequency of deaths. Total observed deaths are often essential for comparisons of changes in 
time trends between age groups, gender and population groups at a given time.  Therefore, to 
compare differences in mortality among age groups, gender and population groups over time, 
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total observed deaths must be associated to the exposed population at risk during the specific 
period. 
 
Mortality can be modelled using survival models of analysis where a set of statistical 
approaches is used to investigate the lapsed time for death to occur (Collet 2015). The definite 
time of survival for an individual, t (time to mortality), could be considered as the value of the 
confounding variable, T (observing Time), which is an element of real numbers.  T defines a 
random variable associated with an individual survival time and Probability distribution is 
formed as values of T are observed. Assuming that a random variable T has a probability 
distribution with probability density function 𝑓(𝑡),  the cumulative distribution function of T 
is given by 𝐹(𝑡) = 𝑃(𝑇 < 𝑡) = ∫ 𝑓(𝑢)𝑑𝑢
𝑡
0
, which implies that the probability of definite 
survival time is greater than the survival time. The function for survival time, S(t), is defined 
to be the probability that the survival time is greater or equal to t, and so 𝑆(𝑡) = 𝑃(𝑇 ≥ 𝑡) =
1 − 𝐹(𝑡).  Therefore, the probability that an individual survives from the time of existence to 
some observed period beyond the definite survival time t is represented by the survival 
function. 
 
TB and HIV-related mortality have remained among the top 10 leading causes of deaths in 
South Africa for many years (STATSSA 2015, STATSSA 2017, Pillay-van Wyk 2016). 
According to Johnson and Dorrington (2017), deaths attributable to AIDS-related causes in 
2017 were estimated at 230,000 of all average deaths while TB alone was responsible for over 
33,063 deaths in 2016 (UNAIDS 2016). Mortality patterns associated with age strongly 
reflects a combination of a simple underlying ageing effect, which can be used as a good 
indicator of the epidemiological profile of a specific population (Ngom and Clark 2003).  
According to Herbest, Mafojane and Newell (2011), the majority of mortality attributable to 
TB and HIV are among age group 25-54 years, which is the most economically active 
population. Therefore, to mitigate the possible negative impact on human development, it is 
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fundamental to measure mortality levels and patterns of mortality due to TB and HIV-related 
causes during adulthood. 
 
The influence of HIV/AIDS on the age pattern of adult mortality has been reported to be 
striking with a much-focused effect at reproductive age (Pillay-van Wyk et al. 2016). Statistics 
South Africa (2017) reported that 12.4% of mortality between age group 15-44 years was 
attributable to TB, while 10.5% were caused by HIV-related causes in the year 2017. Although 
there are implications taken to reduce and eliminate the burden of HIV and TB in South Africa, 
mortality due to TB and HIV/AIDS remain high (STATSSA 2017). 
 
In South Africa, TB and HIV-related causes are ranked the leading infectious cause of death 
since 1997 and remained unchanged till date (STATSSA 2015, Pillay van Wyk et al. 2016, 
Adeiza, Abba and Okpapi 2014). The rates of mortality due to both HIV and TB combined 
were observed to have rapidly increased from 1997, reached a peak during the period 2006, 
and then declined with time periods (STATSSA 2015). The interaction between HIV and TB 
in the sub-Saharan countries has also been associated with higher mortality rate, where as a 
result, 25% of deaths were attributable to HIV in 2010 compared to 12% in the year 2000 
(Adeiza, Abba and Okpapi. 2014). The downward trend of HIV and TB mortality rates 
evaluated by period in years has been observed in most African countries such as Ethiopia, 
Kenya, Mozambique and Nigeria during the year 2004-2008 (Bendavid et al. 2012). A study 
conducted in South Africa also found a rapid decline (from 56% to 39%) of mortality due to 
HIV during the year period 2000-2009 (Herbst, Mafojane and Newell 2011). 
 
Estimations of mortality are often analysed as age-specific, gender-specific and cause-
specific, as exemplified by the annual mortality report given by the Statistics South Africa, 
South African Medical Research Council (SAMRC), Department of Health (DOH) and World 
Health Organization (WHO). An investigation of mortality trends over a long period of lime 
by various demographic characteristics provides some crucial information and portrays a 
better picture to understand mortality. Such crucial information on mortality trends by age-, 
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gender-, race-, and cause-specific classifications have been reported in South Africa 
(STATSSA 2015, Dorrington et al. 2018, Groenewald et al. 2017).  Furthermore, an 
application of statistical analysis could also provide a better insight of the effects of 
demographic characteristics on mortality patterns at a specific time. 1.2 Statistical methods 
of analyses of HIV and TB mortality 
 
Studies to investigate TB and HIV-related mortality have been undertaken globally including 
(Biset ,2017), Gesesew et al. (2016), Lima et al. (2016) Podlekareva et al. (2014)) since their 
epidemic were different statistical methods have been adopted. Some of the studies sought to 
describe epidemiological patterns, determine predictors of TB and HIV-related mortality rates 
and   distinguished the relationship between TB and HIV-related mortality.  A study conducted 
in Ethiopia assessed the predictors of mortality among HIV infected population who were 
known to be taking antiretroviral treatment using meta-analysis (Biset 2017). Factors like 
advance disease stage, low CD4 count, baseline weight and poor treatment adherence were 
significantly associated with HIV-related mortality.  Other factors which were found 
statistically significant to HIV/TB co-infected patients in Southwest Ethiopia were age (35-
44), being a female sex worker, bed ridden patients and disease stage, Gesesew et al. (2016).  
Gesesew et al. (2016) study adopted Cox regression model to assess the predictors of 
mortality. Furthermore, similar factors were reported by Aung et al. (2018) for the TB-HIV 
co-infected patients aged 15 years and above of Myanmar, using cox proportional hazard 
model. 
 
In addition, cox proportional hazards regression has also been utilized to estimate the HIV-
cause specific associated and the outcome of antiretroviral treatment to reduce mortality 
among TB patients in Kenya (Onyango et al. 2017). The study found that the probability of 
mortality out of patients who were not on treatment were four times greater compared to 
patients receiving treatment. Podlekareva et al. (2016) also adopted Cox models to study the 
TB-HIV co-infected mortality among the European and American population. The study 
showed that mortality differs in among this group of people differs by residential area.  
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Application of Cox proportional hazards regression models showed a its significance in 
comparing hazards ratios and predicting associated factors with TB and HIV-related mortality 
in Rio de Janeiro, Brazil, da Silva Escada et al. (2017).  
 
Logistic and Poisson regression models have also gained momentum to predict factors 
contributing to HIV-related and TB mortality. Podlekareva et al. (2014) studied short and 
long-term mortality and causes of death in HIV/TB-related mortality in Europe using Poisson 
regression while Takarinda et al. (2017) used logistic regression to determine the factors 
related with mortality among TB patients in Zimbabwe. Gaifer (2017) reported confounders 
for TB mortality in Oman for the period of 10 years (2006-2016) using logistic regression was 
applied. Risk factors reported in Zimbabwe were not different from risk factors reported in 
Oman. In Texas, a multiple logistic regression was utilised to develop and validate a 
prognostic score for predicting mortality during TB treatment in TB-HIV co-infected 
population (Nguyen, Jenkins and Graviss 2018). Time series analysis was found useful to 
describe the patterns and time trends of TB-HIV-related mortality in Brazil (Lima et al. 2016).  
 
In South Africa, a structural equation modelling approach was applied to examine HIV/TB 
mortality determinats and  the spatial allocation in the rural regions (Musenge et al. 2013). 
Spatial models in this study showed that areas without any health facilities experienced 
highest child HIV/TB mortality while Namosa et.al (2013)  found that peri-urban communities 
of South Africa were associated with higher HIV-related mortality. A spatio temporal analysis 
was used to examine  HIV-associated mortality in rural western Kenya,  (Sifuna et al. 2018) 
where hot spot analysis was used. Queiroz et al. (2018) described epidemiological profile, 
analysed the spatial patterns and investigated temporal trend of mortality due to TB in 
Northeast Brazil and geographical areas with high prevalence of TB mortality. Studies 
conducted across contries show available evidence that Spatio-temporal models are essential 
in studying TB and HIV-related mortality across geographical areas. 
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Models of analyzing count data have been found useful, especially in the field of epidemiology 
where rates of different health outcomes can be measured over time (Tetteh-Ahinakwa and 
Oduro 2017, Russo et.al 2012, Bourne et al. 2009, AA and Naing 2012, Osagie and Adebukola 
2017). These models produce a formal technique to investigate potential interrelations on the 
average mortality rate and the specific risk factors with respect to the exposed population. 
Furthermore, they also allow comparisons of health outcome rates among different exposure 
groups under investigation controlling for confounding factors, where confounders are 
estimated independently. On the other hand, age, period, and cohort model (APC) have been 
found profitable to analyse the attributes of mortality trends over the period of time (Wang 
et.al 2015). This model estimates the effects  age, period and birth cohort simultaneously on 
mortality rates, where the researcher investigate the manner in which mortality among the 
particular age groups changes with time and by cohort and how age-specific death rate pattern 
changes related to birth cohorts (Yang and land 2013). In addition, it may be used to better 
depict the demographical, environmental and social factors that jointly affect individuals and 
study population over a given period (Yang and Land, 2016). Furthermore, to yield a better 
overview of mortality over a range of studied populations; age, period to mortality and birth 
cohort should be taken into consideration. Nevertheless, there are no studies in South Africa 
that examined the trend of TB and HIV-related mortality using age-period-cohort (APC) 
model, which has been reported to be more effective than traditional cross-sectional analysis 
in analyzing trends (Chang et al. 2011, Gao et al. 2017). Therefore, this study used APC model 
to estimate age, period and birth cohort effects jointly on TB and HIV-related mortality using 
a Poisson distribution on the counts of cause-specific deaths, with log-linear link on the 
Poisson mean. 
 
1.3 Related Studies (Age-Period-Cohort Analysis) 
 
The utilisation of the APC models is a widely known tradition in medical sociology. It 
measures the variation of birth, corresponding with the shifts in the population that are 
exposed to risk factors over time. The APC models have been used for the analysis of the 
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trends in the long-term mortalities of various chronic diseases including cancer, diabetes, 
epilepsy etc. The significance of the APC analysis has been reported in measuring the 
incidences, prevalence and the mortality trends in different parts of the world. Suddenly, APC 
analysis is gaining momentum in analysing the cause of mortality worldwide (Ocaña-Riola 
et.al 2013, Chang et.al, 2011, Gao et.al, 2017). 
 
 An effect of overall mortality in Andalusia was reported by Ocaña-Riola, Mayoral-Cortés 
and Blanco-Reina (2013) where Lexis diagram was used to tabulate the death per individual’s 
age and cohort, and the period effect was evaluated. The effects of age, period and cohort in 
all geographical areas of Andalusia were   evaluated and a tangible evidence about the time 
trends of all age groups mortality was provided. 
 
A study conducted in Taiwan employed the three phases of age-period-cohort analysis to 
compare the pattern of epilepsy cause-specific mortality in European Union and United 
Kingdom (Chang et al. 2011). Age and period effects were found to be statistically significant, 
though the cohort effect was not significant. Regardless of the age and period effects found, 
the overall effects of the epilepsy mortality in Taiwan were different from those of European 
Union countries compared to the United Kingdom countries.  
 
Gao et al. (2017) employed the APC analysis to describe the time trends of mortality due to 
oesophagal cancer in China. Of the recorded deaths from 1989 to 2013, the effect of age in 
this cohort was reported from the age of 30 to 84 years while the period and cohort effect 
declined from 1989 to 2003 and 1910 to 1980s respectively. 
 
The first study to use the APC analysis to compare the trends of breast cancer across East Asia 
to the United States trend was conducted by Wang et al. (2015). The APC models estimated 
when and how the three dependent covariates affected the breast cancer cause-specific 
mortality trends. At age 20 to 54, there was an increase in mortality due to breast cancer 
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associated with age in all areas. However, after age 55 the United States pattern differed from 
the East Asian. 
 
Another study aimed to investigate the effects of age, period and cohorts on the temporal trend 
of type I diabetes in children under 15 in Italy (Bruno et al. 2010). Poisson regression models 
were used to model sex, age, period and cohort effects considering registry-level variance 
component. The incidence of type I diabetes among the children in Italy was reported to have 
increased within the time frame of the study. However, the increase could not be ascribed to 
either the calendar time or birth cohort. The use of APC model provided evidence on the 
ability to monitor disease incidence rate. 
 
These models have not only gained popularity in studying effects of three factors on mortality 
and burden of diseases but have also been utilised to study the effects on incidence and 
prevalence based on social, cultural and environmental factors. Jee and Cho (2016) conducted 
a study to identify the contributions of age, period and birth cohort effects on smoking 
prevalence in young adult’s men in Korea. Age-period-cohort analysis was applied with the 
aim of identifying independent effects, where the smoking prevalence was adjusted to 2008 
population. Results of this study showed a significant increase with age, increasing with 
smoking prevalence and declining with the increasing of period and cohort. 
 
1.4 Overall Objectives 
 
Different statistical methods including logistic regression, poisson regression, cox 
proportional and spatio temporal analysis have been used to estimate mortality due to TB and 
HIV-related cause. Given the array of methods available, the main purpose of this study is to 
estimate age effect across period and birth cohort, period effect across age and birth cohort, 
and birth cohort effect across age and period on TB and HIV-related mortality. This was done 
using Age, period, cohort analysis which has not been applied to this type of data before. 
Mortality data and Mid population estimates acquired from statistics south Africa for the 
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period 1997-2015 will be used to describe time trends of TB and HIV-related mortality. This 
will be given by age specific mortality rates per 100 000 residents if South Africa. Estimations 
of the mortality are often analysed as age-specific, gender-specific or cause-specific 
separately, which may provide a better understanding of the mortality rates investigated. For 
this study, effects of age, period and birth cohorts will be estimated simultaneously. To 
estimate effect of age, period and birth cohort, the number of deaths over 3-year interval for 
age, period and birth cohorts for 15-64, 1997-2015, and 1934-2000 respectively will be drawn 
from the data. The effects of age, period and birth cohort will be estimated using a Poisson 
distribution on the counts of cause-specific deaths, with log-linear link on the Poisson mean. 
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CHAPTER 2: METHODOLOGY 
 
2.1 Introduction 
 
This chapter described an overview of the utilised methods, study site, and the population as 
well as the variables of interest of the data used for this study. Age-period-cohort (APC) 
models are described fully. 
 
2.2 Overview of Age-Period-Cohort Analysis 
 
APC models were firstly introduced by demographers and sociologists in the 1970s and have 
been proven to provide insights into the effects of age, period and cohort on observed changes 
over various health outcomes. Analysis of age, period and cohort models have widely been 
used in descriptive epidemiology to evaluate the mortality trends, prevalence, and incidences. 
 
Age effects measures the variations related with various age groups created by aggregation of 
experience, and physiological diversity. Age effects measures the features of individual’s 
ageing processes t and developments observed during the lifetime. Furthermore, period effects 
evaluate changes of health outcomes over time which are influenced by all age groups 
simultaneously (Yang and Land 2008). Historical events and environmental factors including 
epidemics and pandemics of infectious diseases are represented by effect of period. Lastly, 
birth cohort effects determine the differences across a group of people who experiences the 
health outcome   in the same year. Usually, birth cohort effect arises as a result of mortality 
distributions occurring from an exposed group separately impact age groups.  
 
The APC models parameters combine time effects for age, period and cohort, where age 
effects are observed within the age groups while a birth cohort effect is considered an 
association due to period effect (Holford 1983). In most studies where the APC models have 
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been utilised, the available evidence suggested that the analysis can provide useful 
interpretation of the time trends of a disease and mortality rates (Ocala-Riola, Mayoral-Cortés 
and Blanco-Reina 2013, Rosenberg and Anderson 2011). Moreover, these models perfom a 
crucial role in understanding the time-varying elements of burden of diseases and mortality. 
 
Although APC models are vital to study time trends of incidence and mortality rates, the 
model suffers the identification problem (Holford 1983, Yang and Land 2008, Yang, Fu and 
Land 2004). Age, period and cohort are known to be highly correlated, which causes the se 
identification problem between the three factors. That is, if the value of two of these variables 
are given, t the third variable can be estimated (period = age + cohort). Several researchers 
have  attempted to solve the identification problem where different methods have been 
proposed including, using prior information to impose parameter constraints,  non-informative 
constraints causal models to approximate for age, period and cohort effects, and  estimable 
functions of the APC model parameters, intrinsic estimator and application of Bayesian 
smoothing models (Yang and Land 2008, Luo 2013, Holford 1983). These attempts, were 
started decades ago, continue to date.  
 
Conventional APC models such as Constrained Generalised Linear Models (CGLIM) have 
been used to resolve an identification problem by finding a relevant constraint of either age, 
period or birth cohort (Yang and Land 2008, Yang et al. 2008). However, the method has 
significant limitations; regarding finding the relevant constraint, which depends on the 
additional, a priori, and information. However, researchers have found it difficult to acquire 
or verify that prior information. This method is useful to establish the degree of sensitivity to 
various changes in coefficient constraints. The results from the method, however, are not fixed 
and are difficult to interpret (Yang and Land 2008). Therefore, recent researchers of APC 
methodology have studied the estimable function, which is not dependent on the variation of 
constraints.  
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Apart from using constrained GLM, Bayesian Ridge Estimation of Age-Period-Cohort 
Models can also be considered to solve collinearity problem using ridge priors (Duzan and 
Shariff 2015, Xu and Powers 2016). Ridge estimator has been reported as appropriate 
technique to find the desirable parameters for age, period and birth cohort under investigation.  
 
Another alternative technique suggested by Yang et.al (2004) is Intrinsic Estimator (IE) 
model. This model has been proven to yields trustworthy estimates of age, period and birth 
cohort on mortality and morbidity, which determine the unique coefficients. Through 
empirical analysis utilising the IE model, Yang et al. (2004) concluded that it can be a useful 
alternative to conventional methods of APC. For any fixed number of periods, the IE model 
is not only unbiased but has a smaller variance compared to other conventional model. Luo 
(2013) assessed the validity and application scope of IE theoretically where constraint depends 
on the number of age groups, periods, and birth cohorts’ categories has and non-trivial 
inferences for estimations.  
 
2.3 Modelling 
 
To study age effect across period and birth cohort; period effect across age and birth cohort; 
and birth cohort effect across age and period on mortality due to TB and HIV from 1997 to 
2015 in South Africa, Age, Period and Cohort analysis was undertaken. The usual APC model 
is an additive model for the log rate of mortality. Let 𝑖(1, … , 𝐼) index the age groups, where 
age group 1 includes 15-17 years old, age group 2 includes 18-20 years old, and so on ; 
𝑗(1, . . , 𝐽) index 3 year period, with period 1 as 1997-1999, period 2 as 2000-2002, and so on; 
and 𝑘(1, … , 𝐾) index cohort. Assuming that age and period are divided into equally spaced 
intervals, we have, I=17, J=7 and K=23, that is, 𝐾 = (𝐼 + 𝐽) − 1 (Appendix I). The following 
assumptions were decided upon during the model construction. 
 
The classical Lee-Carter (LC) method for modeling TB and HIV-related mortality rates is 
given by 
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𝑰𝒏(𝑹𝒊𝒋𝒛) = 𝒂𝒊 + 𝒃𝒊𝒕𝒋 + 𝜺𝒊𝒋𝒛      (1) 
Where. 𝑅𝑖𝑗𝑧 denotes the matrix of age-specific mortality rates for age i at time period j and for 
a cause-specific z, 𝑎𝑖 represents the mean age-specific mortality, 𝑏𝑖 is the rate of change in 
TB and HIV-related mortality at age i, 𝑡𝑗 indicates the TB and HIV-related mortality index at 
period j and 𝜀𝑖𝑗𝑧 is the residual term at age i and period j (Lee and Carter (1992)).  
The Lee-Carter model assumes that residual term at age i and period j are distributed normally 
with mean 0 and variance 𝜎2, while a change of mortality remain fixed over time for all 
defined age-groups and overall trend (𝑡𝑗) is fixed for all age at a given period. Our model 
parameter for mean age-specific mortality rates (𝑎𝑖) over time period j is then estimated as 
follows: 
?̂? =
𝟏
𝒋
∑ 𝑰𝒏(𝑹𝒊𝒋𝒛)
𝒋
𝒕=𝟏         (2) 
According to Lee and Carter (1992), the age and period parameters on the right side of (1) 
cannot be observed, therefore ordinary least squares (OLS) approach cannot be used to 
estimate the parameters of 𝑏𝑖 and 𝑡𝑗. Since the OLS approach is not plausible, Lee and Carter 
proposed a singular value decomposition (SVD) matrix to obtain the least squares estimates 
by transforming age-specific mortality vector into a mortality index scalar where the 
parameters are subjected to the following constraints: 
∑ 𝒃𝒊
𝟐 = 𝟏,     ∑ 𝒕𝒋 = 𝟎
𝒋=𝑱
𝒋=𝟏
𝒊=𝑰
𝒊=𝟏                                                    (3) 
From equation (1) and (2), 𝑏𝑖 and 𝑡𝑗 parameters are estimated by creating a matrix  
𝑨𝒊𝒋 = (𝑰𝒏𝑹𝒊𝒋) − ?̂?𝒊     (4) 
Which can be broken down into three matrices; age component (A), singular values (X) and 
period component (T) by applying SVD which takes a form  
  𝑺𝑽𝑫(𝑨𝒊𝒋) = 𝑨𝑿𝑻
′                                 (5) 
By applying constraints of  𝑏𝑖 and 𝑡𝑗 (3), the estimates of 𝑏𝑖 and 𝑡𝑗 are therefore given by  
 ?̂?𝒊 =
𝟏
∑ 𝒂𝒊𝟏
𝟐
𝒋
 ⋅ (𝒂𝟏,𝟏  𝒂𝟐,𝟏 𝒂𝟑,𝟏 … ….   𝒂𝒊,𝟏)                      (6) 
 and 
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?̂?𝒋 =  ∑ 𝒂𝒊,𝟏
𝟐   . 𝑿𝟏 .𝒊 (𝒕𝟏,𝟏  𝒕𝟐,𝟏 𝒕𝟑,𝟏 … ….   𝒕𝒋,𝟏) .          (7) 
The estimates of log of cause-specific mortality are therefore estimated by  
            𝑰𝒏?̂?𝒊𝒋𝒛 = ?̂?𝒊 + ?̂?𝒊?̂?𝒋 = ?̂?𝒊 + ?̂?𝒊𝒋          (8) 
Although LC model can yield accurate average mortality rates for countries with available 
vital registrations over time, it has some limitations. Based on the assumption that overall 
mortality trend remains fixed over all age groups for a given period, this result to an over 
estimation of the modelled mortality. Furthermore, LC model limit the mortality rate of each 
age given that the log of mortality rate could be a linear function of time, which eventually 
causes mortality rates of all ages to be 0. Since the estimates of LC are over-parametrized and 
is implausible to be applied to many country- and cause-specific mortality data which it was 
not designed for.  Renshaw and Haberman (2006) introduced the cohort extension of the age-
period model given by equation (1) is defined by  
𝒍𝒐𝒈(𝑹𝒊𝒋) =  𝜶𝒊  + 𝒃𝒊𝒕𝒋 + 𝒃𝒊𝜸(𝒋−𝒊) +  𝜺𝒊𝒋                                            (9) 
Here 𝛾 =  (𝛾1−𝐼 , . . . ,  𝛾𝑗  ) represents cohort effects. Again, this model is over-parametrized; 
due to the non-identifiable problem (𝑗 = 𝑖 + 𝑘). Here we have  2𝑖 − 1 parameter for the age 
effects and 𝑗 − 1 for the period effects.  
 
Identification Problem 
Suppose the effect of age, period and cohort are given by 𝜶𝒊𝒛, 𝜷𝒋𝒛 and 𝜸𝒌𝒛 for deaths due to 
diseases 𝑧 = 1 (𝑇𝐵) 𝑎𝑛𝑑 𝑧 = 2 (𝐻𝐼𝑉). Assuming that the three factor has an additive effect 
on the log rate, one can model the natural log as; 
 𝑰𝒏 (𝑹𝒊𝒋𝒌𝒛 ) = 𝝁 + 𝜶𝒊𝒛 + 𝜷𝒋𝒛 + 𝜸𝒌𝒛 + 𝜺𝒊𝒋𝒌𝒛,                                    (10) 
 
which can be fitted using linear model and 𝜺𝒊𝒋 is the random error. However, direct 
interpretation of these effects is difficult because the model is over parametrized. There are 
two sources of identifiability to consider. The simpler one to account for is that which always 
occurs in models with factors: with an intercept in the model, we have one more level than is 
estimable and so a constraint is required. A typical solution is to impose a sum-to-zero 
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constraint. The more indirect form of non-identification transpires because three factors (age, 
period and cohort) are linearly dependent, and there is no solution to this problem. Instead, 
one must make assumptions if one wishes to directly interpret the parameters in equation (10). 
Further, these assumptions are uncheckable from the raw data alone. 
 
 In most cases, the number of deaths 𝑶𝒊𝒋𝒌𝒛, are taken to be independent Poisson distribution 
with mean (𝜆𝑖𝑗𝑘𝑧) depending on Age, Period, and Cohort effects. Model (10) fall into the 
family of Generalized Linear Models (GLMs), it takes a log-linear regression form using a 
log-link function and can be modelled as; 
     𝑰𝒏 (𝝀𝒊𝒋𝒌𝒛 ) = 𝒍𝒐𝒈(𝑵𝒊𝒋𝒌𝒛) + 𝜶𝒊𝒛 + 𝜷𝒋𝒛 + 𝜸𝒌𝒛 + 𝜺𝒊𝒋𝒌𝒛                       (11) 
 
Since Age-Period-Cohort analysis suffer from identification problem, some parameters are 
constraints to zero   in order to avoid the problem.    
                               ∑ ∝𝒊𝒛
𝑰
𝒊=𝟏  =  ∑ 𝜷𝒋𝒛  =  ∑ 𝜸𝒌𝒛  =  𝟎
𝑲
𝒌=𝟏
𝒋=𝑱
𝒋=𝟏                                         (12) 
This problem persists due to the exact linear relationship of the age, period and birth cohort, 
which makes it impractical to recognize the individual contributions time effects factors, 
(Holford 1983).  
After the constraining parameters to zero (12), and when 𝑹𝒊𝒋𝒌𝒛 is normally distributed, model 
(10) can also be presented in a form of a matrix for a linear model as follows: 
𝑹 = 𝒀𝒃 + 𝜺              (13) 
where 𝑹 is a mortality rates column vector, 𝒀 is the dummy variables design matrix and 𝒃 is 
a model parameter vector,  
                                  𝒃 = (𝝁, 𝜶𝟏,. . 𝜶𝜶−𝟏, 𝜷𝟏, … 𝜷𝒑−𝟏, … . , 𝜸𝟏, … 𝜸𝒂+𝒑−𝟐)
𝑻,                     (14) 
where 𝜺 is a random errors vector with mean 0 and variance 𝝈𝟐where ordinary least squares 
method can be adopted to obtain model parameter estimates vector 𝒃:  
?̂? = (𝒀𝑻𝒀)−𝟏𝒀𝑻𝑹              (15)  
where the indexed 𝑻 denotes the transpose and the indexed −1 represent the inverse. Since at 
least one of the columns of 𝒀 can be rewritten as a function of the other columns, the design 
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matrix 𝒀 is a rank deficient one (i.e. singular). Consequently, a regular inverse (𝒀𝑻𝒀)−𝟏 does 
not exist and Eq.15 cannot be estimated without an additional constraint.  
 
The right side of equation 14 gives lot of information that helps in understanding how singular 
design matrix incurs during estimation of model parameters. The following property is 
obtained when design Matrix 𝒀 is less than full column rank,  
𝒀𝒃𝟎  =  𝟎               (16)  
Where 𝑏0 is a zero vector to so that the product of a vector and a design matrix becomes 0. In 
this case, our null space design matrix 𝒀 contains an empty eigenvector 𝒃𝟎 that aligns with 
eigenvalue of zero. Therefore, 𝒃𝟎 is estimated by decomposing 𝒃 in Eq (14) into two 
components, which represent non-null and null spaces of the design matrix Y as follows:   
𝒃 = 𝒃𝟏  +  𝒒𝒃𝟎               (17)          
where 𝒃𝟏 is the prediction  of 𝒃 on the non-empty space of 𝒀, 𝒃𝟎 is the prediction of 𝒃 on the 
empty space of our design matrix 𝒀, and 𝒒 is an unpredictable scalar which produces crucial 
underlying understanding of identity problem. as the scalar 𝒒 possesses any real number, the 
age, period and birth cohort effects also change (eq 17). Nonetheless, our column vector 𝑹 is 
not affected by various values of 𝒒, as shown in the following equation: 
        𝑹 =  𝒀𝒃 +  𝒆 =  𝒀(𝒃𝟏 + 𝒒𝒃𝟎)  =  𝒀𝒃𝟏  +  𝒒𝒀𝒃𝟎                        (18) 
where 𝒒𝒀𝒃𝟎 is equal zero since 𝒀𝒃𝟎  from equation (16) is also zero. This implies that the 
column vector 𝑹  is dependent to 𝒀𝒃𝟏. Therefore, 𝑹 can take ant non-negative value that 
represent various arrays of age, period and birth cohort effects depending on the value of  𝒒. 
Identification problem defined in this case arises when the true values of 𝒃 cannot be classified 
in terms of three time-components factors. Yang et.al (2004) developed an intrinsic estimator 
(IE) models to solve the persisting problem of the APC models which models the mortality 
rates of a subspace 𝒀 by adopting principal component analysis methods which reduces the 
dimensions of analysis by 1 dimension and eliminates eigenvector 𝒃𝟎. Suppose. 𝑽 =
[𝒗𝟏, 𝒗𝟐, . . , 𝒗𝟐(𝒂+𝒑)−𝟒] and 𝜦 = [𝝀𝟏, 𝝀𝟐, . . , 𝝀𝟐(𝒂+𝒑)−𝟒] are eigenvector  and eigenvalue of 
𝒀𝑻𝒀 respectively, our new PC space design matrix.  in the non-null subspace is defined by:  
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𝑾 =  𝒀 ∙ 𝑽’               (19) 
where 𝑽’ has an interval of 𝟐(𝒂 + 𝒑) − 𝟒 by 𝟐(𝒂 + 𝒑) − 𝟓, consisting of eigenvector which 
are non-empty. 
 
 IE algorithms yields some advantages over other techniques of solving identity problem 
including CGLIM, using prior estimator and Bayesian approximation methods (Yang et.at 
2004). These methods have been found to produce unbiased estimator depending on the 
number of categories of age and period as well as their width intervals. Though, there are no 
available literature to back up the theory behind the IE’s and on the selection of definite 
constraints, this technique has been proven to produce plausible estimates. Moreover, IE are 
recommended to produce efficient estimates than CGLIM models (Yang et.al. 2004) 
 
All coefficients were estimated using the log-linear Poisson regression model. The temporal 
variations of mortality by each cause were examined based on age-period, age-cohort, period-
cohort and age-period-cohort. The logarithmic transformation of mortality rates allows the 
formulation of generalised linear model (GLM) presented by the linear equation above, where 
µ denotes adjusted mean deaths and 𝜺𝒊𝒋 denotes random error. The robustness of the APC 
model with various combinations of age, period and cohort was evaluated using deviance, log-
likelihood, Akaike Information Criteria (AIC) and Bayesian Information Criteria (BIC). A 
model with lower AIC, BIC and deviance was considered the most suitable model. 
 
2.4       Ethical considerations 
 
Data for this study are publicly accessible and include no personal identifiers. Therefore, no 
ethical review of the study protocol consent was necessary. These are secondary data which 
are recorded by the Department of Home Affairs (DHA) and Statistics South Africa processes 
and compiles them for public use. 
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CHAPTER 3: DATA DESCRIPTION AND RESULTS 
 
3.1 Introduction 
 
Data handling and the statistical approach adopted to analyse data in this study were described. 
Results of the analysis of the TB and HIV-related mortality data for the period 1997-2015 are 
presented in this chapter. Summary statistics are given by means of frequency and percentages 
for each cause-specific mortality and age. Age-specific and adjusted mortality rates are 
reported per 100,000 residents of South Africa together with their corresponding mortality 
plots. Estimated risk ratios are also presented adjusting for age, period and birth cohort. 
 
3.2  Data  
 
To study HIV and TB mortality trends, official mortality data obtained from Statistics South 
Africa was used. These data provide demographic information such as gender, age, death year 
and place of residence. Mortality data in South Africa are registered with the Department of 
Home Affairs (DHA) using the death notification forms. Statistics South Africa processes and 
compiles the mortality records forms into annual publications (STATSSA 2015). The 
mortality due to HIV and TB data was analysed for the years 1997-2015. The underlying 
causes of death were extracted using the ICD-10 (International Classification of Diseases) 
which are developed by the World Health Organization (WHO) and which the United Nations 
(UN) states members agrees and adheres to (WHO 2010). TB codes included A15 to A19, 
U51 and U52 while HIV codes range from B20 to B24. For this study, adults between the 
ages of 15 and 64 were considered where the standardised age groups, 15-24, 25-44, and 45-
64 were utilised. 
 
Statistics South Africa compiles mid-population totals at country level as well as at provincial 
level from 2002 till to date. However, this study covered death data from 1997 to 2015. 
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Therefore, for the years 1997 to 2000, an exponential growth rate from census 1996 was used 
to estimate the mid-population. The formula used is as follows: 
𝑷𝒕+𝒏 = 𝑷𝒕𝒆
𝒏𝒓 ,  
where 𝑛 is the length of time, 𝑟 is the rate of population growth, and 𝑷𝒕 is the total population 
at time 𝒕.  Mid-population estimates for the year 2001 was obtained from the 2001 census 
report. For each cause-specific mortality, rates for each age group were calculated as per 
100,000 residents of South Africa, that is, the proportion of the population dying from either 
TB or HIV and population at risk.  
 
3.3      Results 
 
Table 1 presents overall mortality rates of adults aged 15-64 by sex, age and cause. In 2015, 
a total of 1,162,832 adults’ deaths from TB and HIV were registered in South Africa. The 
highest proportion of deaths was among the age of 25 to 44 years, followed by 45 to 64 years, 
63.2% and 29.3% respectively. Considering deaths due to TB and HIV and among age 15-64, 
TB cause-specific mortality was accountable for 910 731 (78.3%) deaths by the year 2015, 
while 252, 101 (21.7%) deaths were observed for HIV cause mortality.  
 
Table 1: Distribution of deaths by cause-specific and age groups, 1997-2015 
 
Age Groups 
Number of deaths (%) 
Overall [1, 162 832 
(100%)]  TB [910 731 (78.3)] HIV [252 101 (21.7)] 
 
  
 
  
15-24 87 417 (7.5) 68 291 (7.5) 19 126 (7.6) 
25-44 735 268 (63.2) 561 322 (61.6) 173 946 (69.0) 
45-64 340 147 (29.3) 281 118 (30.9) 59 029 (28.4) 
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Table 2 shows age-specific mortality rates calculated as the number of deaths per 100,000 
residents in South Africa for TB cause-specific and HIV cause-specific, for each year and 
three age groups. TB-specific mortality rates were higher for the age groups 25-44 and 45-64 
compared to age group 15-24 years. Mortality rates increased rapidly with time, reached a 
peak in 2006 and then declined until 2015. A normal distribution pattern was observed for the 
three age groups under study in Figure 1.  
 
Mortality rates due to HIV increases with time from 1997 to 2015 for all age groups, that is 
15-24, 25-44, 45-64 years. Higher mortality rates were observed for age group 25-44 followed 
by age group 45-64, while age group 15-24 had lower rates compared to other age groups. 
Trends for mortality due to HIV are presented in Figure 1, where mortality trends are observed 
to increase and decrease within the periods and age groups. 
 
Table 2: Specific mortality rates calculated for each cause and age groups for each year 
Mortality rates were calculated as number of deaths/estimated population and expressed per 
100,000 persons. 
Year of 
death 
 15-24 25-44 45-64 15-24 25-44 45-64 15-24 25-44 45-64 15-24 25-44 45-64 15-24 25-44 45-64
1997 8417230 11617730 5705371 1575 9745 6632 18.7 83.9 116.2 688 3883 855 8.2 33.4 15.0
1998 8604167 11874984 5831239 2174 13813 7962 25.3 116.3 136.5 778 4592 988 9.0 38.7 16.9
1999 8795291 12137980 5959909 2585 17746 9264 29.4 146.2 155.4 1018 6508 1309 11.6 53.6 22.0
2000 8990697 12406852 6091443 3365 23225 10700 37.4 187.2 175.7 966 6909 1447 10.7 55.7 23.8
2001 9190481 12681729 6225903 4016 29438 12285 43.7 232.1 197.3 850 6092 1275 9.2 48.0 20.5
2002 9394742 12962748 6363357 4634 35896 14275 49.3 276.9 224.3 879 7112 1451 9.4 54.9 22.8
2003 9703620 13128343 6524329 5032 40260 16283 51.9 306.7 249.6 932 7980 1715 9.6 60.8 26.3
2004 9991817 13288949 6677279 5075 42292 17013 50.8 318.2 254.8 1020 9062 2184 10.2 68.2 32.7
2005 10231229 13474486 6824885 5140 43809 18500 50.2 325.1 271.1 1053 9639 2550 10.3 71.5 37.4
2006 10386442 13716965 6968450 5179 44568 19801 49.9 324.9 284.2 1041 9627 2688 10.0 70.2 38.6
2007 10480119 13998671 7121076 5105 44402 19943 48.7 317.2 280.1 934 8818 2618 8.9 63.0 36.8
2008 10532875 14318582 7278399 4677 42266 20433 44.4 295.2 280.7 979 9680 3118 9.3 67.6 42.8
2009 10551264 14666060 7435300 4240 37752 19602 40.2 257.4 263.6 1068 11108 3937 10.1 75.7 53.0
2010 10527466 15057211 7593685 3866 33477 18517 36.7 222.3 243.8 1125 11506 4310 10.7 76.4 56.8
2011 10447446 15505680 7752424 3112 27714 16820 29.8 178.7 217.0 1065 10483 4348 10.2 67.6 56.1
2012 10318325 15980998 7908754 2706 23507 15191 26.2 147.1 192.1 1090 11482 4797 10.6 71.8 60.7
2013 10157010 16482193 8062446 2208 19292 13369 21.7 117.0 165.8 1287 13896 6359 12.7 84.3 78.9
2014 10000435 16983627 8219731 1916 17570 12852 19.2 103.5 156.4 1220 12876 6426 12.2 75.8 78.2
2015 9869209 17473681 8386321 1686 14550 11676 17.1 83.3 139.2 1132 12693 6654 11.5 72.6 79.3
Population at Risk
HIV
Age specific deaths 
(per 100 000)
Observed number 
of deaths by age 
and period
Age specific deaths 
(per 100 000)
TB
Observed number of 
deaths by age and 
period
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Figure 1: Observed TB and HIV-related mortality trends by age groups 
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3.4  HIV-related mortality data 
 
In South Africa, vital data quality issues such as high proportion of misclassification of 
HIV/AIDS deaths, ill-defined causes,  low-quality certification of underlying cause of death 
by health practitioner and headmen (rural areas), and a high proportion of deaths classified as 
undetermined unnatural causes have been identified (Groenewald 2005, Birnbaum 2012 and 
Pillay-van Wyk 2016). Over decades, completeness for death registration has been estimated 
using several indirect demographic and statistical techniques for example, the Brass Growth 
Balance, Generalised Growth Balance, Bennett–Horiuchi or Preston–Coale methods (Hill and 
Queiroz 2010, Silva 2013, Bennett and Horiuchi 1984 and Dorrington 1999). However, these 
methods are best used by national statistical offices, as they require the use of census data and 
an understanding of the different techniques. Adair and Lopez (2018) developed an empirical 
method to estimate death registration completeness, which utilizes data commonly available 
at the national and subnational level. This method has some advantages compared to other 
methods including better accuracy, improved timeliness, application to subnational areas and 
greater simplicity of use. To adjust for under-reporting and misclassification of HIV/AIDS 
death, our study has adopted the indirect descriptive statistics utilized by Fazito (2012) to 
identify and quantify misclassified and under-reported AIDS deaths in Brazil, and 
Groenewald (2005) to identify AIDS related deaths in South Africa. The adopted method for 
adjustment of HIV/AIDS related death has shown its significance in improving mortality 
information at country level, by both age groups and gender (Groenewald 2005).  
 
Cause-of-death statistics are compiled using the International Classification of Diseases (ICD-
10) which enables the identification of the exact cause of death. Statistics South Africa 
manually codes the causes to the 10th version of the ICD-10 and undertakes an automated 
selection of underlying causes of death according to ICD rules. According to ICD-10, 
HIV/AIDS codes range from B20 to B24. Young adults (15-64 years) mortality records of all 
deaths which occurred from 1997 to 2015 in South Africa with information on age, year of 
death, and underlying cause of death were analysed.  Death rates for HIV/AIDS and AIDS-
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related diseases were calculated for each of the three age groups (15-24, 25-44, and 45-64) for 
periods from 1997 to 2015 per 100 000 persons of South Africa. 
 
For this study, ‘misclassified’ deaths are defined as deaths which were due to AIDS but not 
reported as such in the death certificates, while ‘Under-reported’ deaths are referred deaths 
which were not declared or registered in the civil registries. According to the ICD-10 
underlying cause of death selection rules, a death may be considered as HIV/AIDS if there is 
reference to HIV/AIDS in any line of the death certificate, as well as mention of a condition 
that is considered a direct consequence of HIV/AIDS. The conditions that are assumed to be 
direct consequences of HIV/AIDS are: Kaposi's sarcoma, Burkitt's tumour, and any other 
malignant neoplasm of lymphoid, haematopoietic and related tissue, classifiable to C46 or 
C81–96; and any infectious diseases classifiable to A00–B19, B25–B49, B58–B64, B99 or 
J12–J18 (Centers for Disease Control and Prevention 2008).  
 
To adjust for misclassification, potential 28 causes of death were investigated using age-
specific rates trends plotted over time. AIDS-indicators following the same distinct age pattern 
typical of HIV/AIDS age-specific death rates trends plotted over time were selected for 
estimating excess mortality. Statistics South Africa (2016) indicated that 96% of completeness 
of death registration was achieved for 2015 period. Given that, we utilized 2015 deaths rate 
to calculate expected mortality (expected mortality was subtracted from observed mortality) 
and excess mortality from the causes which were identified as AIDS-indicators. Deaths 
records with no information on age were redistributed proportionally to all other age groups 
for the same year of death while deaths due to ill-defined causes were redistributed across all 
other natural causes of death. Expected numbers of AIDS deaths that were coded as ill-defined 
causes were estimated using the proportion of AIDS deaths among all-natural causes of 
deaths.  To adjust for under-reporting, observed number of AIDS deaths were further adjusted 
for incompleteness. To do that, the ratio of overall observed death rate from our working data 
and overall estimated death rate from WHO was subtracted from 1. Furthermore, excess and 
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expected mortality due to ill-defined causes were scaled-up by the proportion of 
incompleteness. 
 
Table 3 presents an observed number of AIDS deaths, excess mortality, adjustment for AIDS 
mortality to ill-defined and completeness, and the revised estimated number of AIDS deaths 
along with corresponding deaths rates per year. Death rates were used to plot the trend 
presented in Figure 2. Out of 28 AIDS-indicator deaths, only four conditions (Cryptococcosis, 
Kaposi's sarcoma, Pneumocystosis and Meningitis due to other and unspecified causes) were 
identified likely to be misclassified for AIDS deaths.  There were a total of 11 968 deaths due 
to Kaposi's sarcoma, 24 166 deaths due to Cryptococcosis, 71 051 deaths due to Meningitis 
(from other and unspecified causes) and 37 294 deaths due to Pneumocystosis related to 
HIV/AIDS deaths from 1997 to 2015; a total of 144 479 AIDS deaths misclassified as other 
diseases. However, a total of 80 438 was redistributed to AIDS deaths due to over estimation 
for the period 1997 to 1999. A total of 33 358 deaths due to ill-defined causes were 
redistributed to AIDS, and 170 624 were added to the number of AIDS deaths to correct for 
completeness of the mortality in South Africa. Altogether, 284 420 deaths were recoded to 
AIDS between 1997 and 2015, representing 53% of all AIDS deaths. Of all deaths recorded 
to HIV/AIDS, 60% were due to incompleteness of deaths, 28% were due to conditions likely 
to be misclassified AIDS deaths while only 12% were due to ill-defined. Revised mortality 
has shown a concave down association between HIV/AIDS cause-specific mortality and rates 
over time with a peak during the period 2006. 
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 Table 3: Summary of AIDS mortality Adjustments in the 15 to 64-year-old South African 
Population: 1997-2015 
 
Year 
Observed 
AIDS 
Mortality 
Observed 
AIDS 
death rates 
Excess 
Mortality 
Adjustme
nt for ill-
defined 
Adjustment 
for 
completeness 
Revised 
number of 
AIDS 
deaths 
Revised 
AIDS 
deaths rates 
1997 5427 20.40 -1569 835 -1100 3594 13.51 
1998 6358 23.34 -1078 1016 -93 6203 22.77 
1999 8835 31.69 -417 1187 1154 10758 38.59 
2000 9322 32.69 799 1228 3041 14389 50.46 
2001 8217 28.27 2366 1103 5206 16892 58.12 
2002 9442 31.88 4022 1247 7906 22616 76.35 
2003 10627 35.21 5643 1419 10599 28288 93.74 
2004 12266 39.93 7350 1623 13495 34733 113.06 
2005 13242 42.38 8515 1751 15399 38908 124.53 
2006 13356 42.15 9722 1827 17323 42227 133.26 
2007 12370 38.52 9537 1745 16924 40577 126.35 
2008 13777 42.34 8752 1872 15937 40339 123.96 
2009 16118 48.86 7955 2174 15195 41442 125.63 
2010 16949 50.64 6796 2239 13552 39536 118.12 
2011 15912 46.81 4467 2102 9798 32279 94.96 
2012 17376 50.29 3562 2264 8676 31879 92.27 
2013 21562 61.38 2328 2683 7516 34088 97.05 
2014 20533 57.52 1688 2539 6340 31100 87.12 
2015 20499 56.54 0 2505 3758 26762 73.81 
Total 252188  80438 33358 170624 536609  
 
 
 Figure 2: Observed and revised HIV/AIDS death rates for the 15 to 64-year-old South 
African Population 
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 3.5 Analysis of the modelled data with reference to HIV/AIDS and TB related 
causes of death 
 
The data covered HIV and TB cause-specific mortality for South Africa between 1997 and 
2015. It was decided to restrict the age range of the dataset to people who were, at year of 
death, equal to or greater than 15 but less than 65 years of age. To highlight the possibility of 
including covariates into the analysis, the gender of patients and the cause-specific mortality 
was included when collapsing the dataset into unique records of age, period, and cohort. A 
three-year age, period and birth cohort intervals for 15-64 years, 1997-2015 and 1934-2000 
were used respectively. This collapse led to (64 − 15) × (2015 − 1997) different age-period 
categories, each of which were further subdivided by date of birth into three categories. This 
gave a total of 238 observations, one for each triangular subset. However, since a completed 
dataset contains insufficient information, cause-specific mortality terms were included. To 
adjust for individual age populations, the Sprague multipliers method of estimation was 
employed. Calot and Sardon (2004) gave detailed information on how Sprague multipliers 
can be utilised to estimate the mid-population per single age. Therefore, the dataset contains 
(119 × 2) observations and population risk-time calculations were performed for single age 
using Sprague multipliers. Data used comprise 16 3-year and 1 2-year age groups ranging 
from 15-64 and 6 3-year and 1 single year period from 1997 to 2015. These yielded 22 
successive 3-year and 1 single birth cohorts of which the oldest was born in 1934-1936 and 
the youngest cohort was born in 2000. A two-way table of modelled data is shown in the 
Appendix I estimated effects are based on the adjusted mortality data.  
 
3.6 Data exploration by three-year age, period and birth cohort intervals 
 
Figure 3 shows the percentage distribution of TB-related mortality by age group over a 3-year 
period interval and 3-year birth cohort. Higher proportion of deaths were observed for age 
group 25-44 -24 followed by age group 45-64 while age groups 15-24 had the lowest deaths 
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across all periods. Observed percentages showed that TB mortality for age group 45-64 
increased with an increase of time while for other remaining age groups, mortality decreased 
with time period. Age group 15-24, 25-44 and 45-64 were born between the birth cohort 1973-
2000, 1952-1990, and 1934-1972 respectively.  For birth cohorts between 1952-1954 to 1958-
1960, mortality was higher for age group 45-64 compared to age group 25-44 years, while 
higher mortality were observed for age group 25-44 birth cohort 1964-1984 compared to all 
other age groups.    
 
Figure 4 shows proportions of HIV-related mortality by age group over a 3-year period 
interval and 3-year birth cohort. HIV-related mortality. Age group 25-44 had higher 
proportions of HIV-related mortality between 1997 and 2015 while age group 15 – 24 had the 
least deaths. HIV-related mortality decreased with period for age group 15-24 and 25-44 but 
increased with time for age group 45-64. Birth cohort 1952-1954 to 1961-1963, age group 45-
64 had higher proportion of HIV-related mortality compared to same birth cohort age 25-44. 
Again, proportion of HIV-related death were higher among age group 25-44 compared to age 
group 15-24 birth cohort 1973-1975 to 1985-1987.The rest of the results are organised by the 
main research question in the study.  
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Figure 3: Percentage distribution of observed TB mortality by age groups over the 3-year 
period and 3-year birth cohorts 
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Figure 4: Percentage distribution of observed HIV-related mortality by age groups over a 
3-year period and 3-year birth cohorts 
 
 
3.7 Mortality relative risk (RR) for TB and HIV cause-specific. 
 
To describe the age, period and birth cohort effects simultaneously, this study used the APC 
model (IE) to analyse TB and HIV-related mortality trends (1997-2015) of South African 
residents aged 15-64 years. To evaluate the robustness of the IE findings, I estimated the 
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relative risks using the the traditional CGLIM model that apply different constraints. Table 4 
and 5 present the estimated relative risk (RR) and 95% confidence intervals for mortality due 
to TB and HIV respectively. The reference group for age, period and birth cohort relative risk 
is the mean influence of all ages, periods and birth cohorts combined (Keyes and Miech 2013). 
Age, period and birth cohorts’ effects trends were plotted based on the relative mortality risk. 
Analysis for HIV-related mortality were conducted using the revised data. 
 
Table 4 shows the estimated mortality relative risk for TB cause-specific mortality using the 
intrinsic estimator and Constrained Generalized linear models and depicted in Figure 5 and 
Figure 6 respectively. Mortality relative risk and 95% confidence intervals are reported. Our 
results show that age, period and cohort have a strong association with TB mortality. 
Controlling for period and birth cohort effects, age effect showed that the relative mortality 
increases as the age increases. Higher mortality was observed for individuals aged 27 years 
and above to 64 years. For the period effect, relative risk increased from 2000, reached a peak 
by the year period 2006-2008 and thereafter decline until 2015, holding age and birth cohort 
effects constant. The cohort effect reflects an aggregate effect of exposure in generations. 
Mortality relative risk was found higher for birth cohort 1934-1936 than birth cohort after 
1934-1936. The results showed an upward trend in Tuberculosis mortality by age to around 
the age of 33-35 years, from which point the trend turned downward continuously to age group 
63-64 years.  There was a progressive upward trend in Tuberculosis mortality between 1997-
2000 and 2006-2008, then declined thereafter to 2015 period. A downward trend between TB 
mortality relative risk and birth cohort was found (1937-2000).  
 
Table 5 shows the estimated incidence rates for HIV cause-specific mortality using the 
intrinsic estimator and Constrained Generalized linear models and portrayed in Figure 7 and 
Figure 8 respectively. Age group 24-26 to 42-44 years were associated with higher mortality 
rates as compared to age groups younger than 24 or older than 44 years, controlling for period 
and birth cohort effects. Keeping age and birth cohort effects fixed, period effect increased 
significantly with time from 1997-1999 to 2009-2011 then declined significantly thereafter. 
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Cohort born in 1964-1966 were associated with higher HIV incidence rates as compared to 
cohorts born before 1964 or after 1966. An accelerating trend in Human Immunodeficiency 
Virus mortality with age, to age group 33-35 years, from which point the trend turned 
downwards until age group 57-59 years then increases again. There was a concave down 
association for HIV-related mortality during the study period (1997-2015). There was inverted 
V-shaped association between HIV-related mortality and birth cohort. 
 
Estimates of age, period and cohort using CGLM approach depends on the choice of 
constraint, which can be by either age, period or cohort. Unfortunately, estimates of the 
CGLIM approach completely depend on constraint chosen and consequently different results 
can be obtained when changing the identification restriction (Appendix III). Therefore, the 
constraints should be chosen carefully. For our study, estimates obtained from each of the 
three constraint are reported and similar significant results to those of the IE solution was 
yielded.  Results are presented in table 4 and Table 5 and portrayed by Figure 5 and Figure 6; 
and Figure 7 and Figure 8, for TB and HIV cause- mortality respectively. The age and birth 
cohort effects are different for TB cause-specific mortality across the two models, while the 
period effects estimated by both models are basically similar. The age, period and birth cohort 
effects estimated by both IE and CGLIM are virtually very similar for HIV cause-specific 
mortality. 
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Table 4: Age-period-cohort estimates for TB cause-specific mortality 
 
Mortality relative risk (exp(b)) and 95% confidence intervals are reported. 
RR RR
Age
15 - 17 0.12 0.11 0.12 1.00 - -
18 - 20 0.29 0.27 0.30 2.22 2.08 2.36
21 -23 0.58 0.55 0.60 4.10 3.82 4.39
24 - 26 0.95 0.92 0.99 6.17 5.72 6.65
27 - 29 1.28 1.22 1.33 7.52 6.89 8.21
30 - 32 1.45 1.40 1.51 7.81 7.07 8.62
33 - 35 1.51 1.46 1.57 7.42 6.64 8.29
36 - 38 1.50 1.45 1.56 6.71 5.93 7.59
39 - 41 1.47 1.42 1.52 6.00 5.25 6.86
42 - 44 1.42 1.37 1.48 5.29 4.57 6.13
45 - 47 1.40 1.34 1.46 4.73 4.03 5.55
48 - 50 1.36 1.29 1.44 4.21 3.53 5.02
51 - 53 1.34 1.26 1.43 3.78 3.13 4.57
54 - 56 1.31 1.22 1.41 3.37 2.75 4.12
57 - 59 1.30 1.18 1.43 3.05 2.46 3.78
60 - 62 1.24 1.12 1.38 2.66 2.17 3.26
63 -64 1.14 0.97 1.34 2.22 2.08 2.36
Period
1997 - 1999 0.60 0.56 0.64 1.00 - -
2000 - 2002 1.10 1.08 1.12 2.01 1.87 2.16
2003 - 2005 1.50 1.46 1.53 3.00 2.77 3.25
2006 - 2008 1.58 1.55 1.61 3.47 3.20 3.77
2009 - 2011 1.25 1.23 1.27 3.01 2.76 3.29
2012 - 2014 0.81 0.79 0.84 2.14 1.93 2.38
2015 0.63 0.61 0.66 1.84 1.63 2.06
Birth cohort 
1934 - 1936 1.62 1.39 1.90 1.00 - -
1937 - 1939 1.34 1.04 1.73 0.75 0.56 1.01
1940 - 1942 1.30 1.04 1.61 0.66 0.51 0.86
1943 - 1945 1.02 0.87 1.19 0.48 0.39 0.58
1946 - 1948 0.97 0.87 1.09 0.41 0.35 0.49
1949 - 1951 1.12 1.01 1.25 0.44 0.36 0.52
1952 - 1954 1.16 1.07 1.26 0.41 0.35 0.48
1955 - 1957 1.14 1.06 1.23 0.37 0.32 0.42
1958 - 1960 1.20 1.13 1.28 0.35 0.31 0.40
1961 - 1963 1.23 1.16 1.30 0.33 0.29 0.37
1964 - 1966 1.30 1.23 1.37 0.32 0.28 0.35
1967 - 1969 1.23 1.17 1.30 0.27 0.25 0.31
1970 - 1972 1.27 1.20 1.34 0.26 0.23 0.29
1973 - 1975 1.22 1.17 1.28 0.23 0.21 0.25
1976 - 1978 1.13 1.08 1.18 0.19 0.18 0.21
1979 - 1981 0.94 0.91 0.97 0.14 0.13 0.16
1982 - 1984 0.80 0.77 0.82 0.11 0.10 0.12
1985 - 1987 0.68 0.65 0.70 0.09 0.08 0.09
1988 - 1990 0.56 0.54 0.59 0.07 0.06 0.07
1991 - 1993 0.53 0.50 0.56 0.06 0.05 0.06
1994 -1996 0.60 0.55 0.66 0.06 0.05 0.07
1997 - 1999 0.76 0.64 0.90 0.07 0.05 0.08
2000 0.85 0.79 0.92 0.07 0.06 0.08
TB Cause-Specific 
Mortality 95% CI
Constrained by Age group: 18-20 = 63-64
95% CI
IE
CGLIM
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Table 5: Age-period-cohort estimates for HIV cause-specific mortality 
 
Mortality relative risk (exp(b)) and 95% confidence intervals are reported. 
RR RR
Age
15 - 17 0.47 0.42 0.54 1.00 - -
18 - 20 0.52 0.50 0.55 1.09 0.95 1.25
21 -23 0.70 0.67 0.74 1.44 1.24 1.68
24 - 26 1.31 1.27 1.36 2.65 2.26 3.11
27 - 29 1.07 1.04 1.11 2.14 1.81 2.52
30 - 32 1.66 1.61 1.71 3.25 2.73 3.87
33 - 35 1.61 1.56 1.66 3.10 2.59 3.72
36 - 38 1.53 1.48 1.58 2.91 2.41 3.51
39 - 41 1.44 1.40 1.49 2.70 2.22 3.28
42 - 44 1.40 1.33 1.48 2.59 2.10 3.18
45 - 47 0.81 0.74 0.88 1.47 1.17 1.84
48 - 50 0.78 0.74 0.83 1.40 1.12 1.75
51 - 53 0.78 0.75 0.82 1.38 1.10 1.73
54 - 56 0.82 0.77 0.87 1.43 1.12 1.81
57 - 59 0.89 0.84 0.95 1.52 1.19 1.95
60 - 62 1.05 0.98 1.13 1.77 1.38 2.27
63 -64 1.29 1.13 1.47 2.14 1.81 2.52
Period
1997 - 1999 0.36 0.34 0.38 1.00 - -
2000 - 2002 0.67 0.66 0.69 1.91 1.80 2.03
2003 - 2005 1.15 1.13 1.17 3.32 3.12 3.53
2006 - 2008 1.41 1.38 1.44 4.12 3.85 4.42
2009 - 2011 1.45 1.42 1.47 4.30 3.99 4.63
2012 - 2014 1.37 1.34 1.40 4.13 3.78 4.51
2015 1.29 1.23 1.35 3.95 3.54 4.41
Birth cohort 
1934 - 1936 0.39 0.35 0.45 1.00 - -
1937 - 1939 0.32 0.26 0.40 0.81 0.64 1.03
1940 - 1942 0.61 0.43 0.87 1.51 1.01 2.25
1943 - 1945 0.89 0.74 1.08 2.17 1.73 2.72
1946 - 1948 1.09 0.98 1.20 2.60 2.31 2.92
1949 - 1951 1.30 1.21 1.40 3.06 2.73 3.43
1952 - 1954 1.48 1.37 1.60 3.43 3.07 3.84
1955 - 1957 1.61 1.51 1.72 3.68 3.35 4.03
1958 - 1960 1.90 1.75 2.05 4.26 3.88 4.67
1961 - 1963 2.08 1.94 2.22 4.60 4.27 4.95
1964 - 1966 2.22 2.10 2.34 4.83 4.56 5.12
1967 - 1969 2.09 1.98 2.22 4.49 4.24 4.75
1970 - 1972 1.93 1.83 2.03 4.07 3.85 4.30
1973 - 1975 1.74 1.67 1.82 3.63 3.45 3.82
1976 - 1978 1.58 1.51 1.65 3.24 3.05 3.44
1979 - 1981 1.29 1.24 1.35 2.61 2.45 2.79
1982 - 1984 1.05 1.00 1.11 2.09 1.93 2.27
1985 - 1987 0.85 0.81 0.88 1.66 1.52 1.81
1988 - 1990 0.70 0.67 0.72 1.34 1.21 1.49
1991 - 1993 0.61 0.57 0.65 1.16 1.01 1.32
1994 -1996 0.54 0.50 0.58 1.01 0.86 1.17
1997 - 1999 0.44 0.40 0.48 0.80 0.67 0.96
2000 0.38 0.34 0.43 0.69 0.56 0.86
HIV Cause-Specific 
Mortality 
Constrained by Age group: 27-29 = 63-64
95% CI 95% CI
IE
CGLIM
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Figure 5: Age, Period and cohort effects of TB mortality. Notes: dotted lines represent 95% 
confidence intervals. 
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Figure 6: Age, Period and cohort effects of TB mortality. Notes: dotted lines represent 95% 
confidence intervals. 
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Figure 7: Age, period and cohort effects of HIV-related mortality. Notes: dotted lines 
present 95% confidence intervals. 
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Figure 8: Age, period and cohort effects of HIV-related mortality. Notes: dotted lines 
present 95% confidence intervals. 
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Table 6 shows the model selection statistics for example deviance and AIC were used to 
choose the best model of two factor and full three factor APC models. Based on the measures 
of estimates, none of the three components of the APC models should be eliminated from the 
model specification. The full APC model fit the data significantly better than the other three 
models. Outputs from the fitted models are shown in Appendix II. 
 
Table 6: Summary of the goodness of fit 
Cause-Specific 
Mortality 
Age and Period 
(AP) 
Age and 
Cohort (AC) 
Period and 
Cohort (PC) 
Age, Period and 
Cohort (APC) 
TB         
Log-likelihood -365127 -395163 -390506 -354507 
Deviance 727230 787302 777988 705991 
BIC 725339 785411 781070 704124 
AIC 2173 2353 781032 2110 
HIV         
Log-likelihood -98680 -96518 -108390 -92250 
Deviance 194811 190486 214229 181951 
BIC 192920 188595 216838 180084 
AIC 588 575 216800 549 
Lower AIC and Deviance indicates best model in each cause-specific mortality. 
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CHAPTER 4: DISCUSSION AND CONCLUSION 
 
4.1      Introduction 
 
This chapter discusses the key findings from the analysis in this study and how it varies from 
or is similar to findings from other studies. The strengths and limitations of the study have 
also been discussed. Future work has been suggested and conclusions are also provided in this 
chapter. 
 
4.2      Discussions 
 
In South Africa, young adult morality is important to provide a reliable population estimates 
and projections that underlie planning in any sector especially with the impact of HIV/AIDS, 
TB, injuries and emerging non-communicable diseases. This study set out to simultaneously 
estimate effects of age, period and birth cohort on mortality due to TB and HIV among young 
adults (ages 15-64 years) in South Africa between 1997 and 2015. An Age, Period and Cohort 
Model based on Poisson Distributions for the deaths counts was used. Our study also adjusted 
HIV/AIDS deaths for misclassification and under-reporting using descriptive statistics.  
 
Findings confirmed the substantial misclassification of HIV/AIDS deaths in South Africa’s 
vital registration system reported in the literature. Our study identified four AIDS related 
conditions which are source of HIV misclassification and revealed a downward trend in HIV 
death rates over time, with a peak during the year period 2006. A concave down association 
between age and TB mortality, with a peak at 33-35 years. There was a concave down 
relationship between TB cause-specific mortality   in the studies mortality data period: 1997 
and 2015. There was a downward trend between TB mortality and the effect of birth cohort 
from 1934 to 2000. There was an inverse flatter U-shaped association between age and HIV-
related mortality and was more pronounced at 30-32 years. The estimated relative risks 
showed an inverse U-shaped relationship between HIV-related mortality and effect of period 
40 
 
from 1997 to 2015. An inverted V-shape relationship between birth cohort and HIV-related 
mortality was estimated. 
Results from age, and period analysis are comparable to official statistics report, global TB 
and HIV-related mortality report and other similar research findings in South Africa, however, 
differs from official statistics of South Africa according to period. Our study showed that age 
groups 36-38 were more at risk of TB mortality than all other age groups, which correspond 
to Kootbodien et.al (2018) findings. We reported a decline of TB death rates in South Africa 
since 2007 to 2015, which is in line with the 68.8% to 77.2% global reduction in TB mortality 
from 2007 to 2014 respectively. The similar trend for TB deaths over time was reported by 
the official statistics of South Africa which was also confirmed by Pillay-van Wyk et al. 
(2016). Furthermore, Day and gray (2015) reported a concave down relationship in TB 
mortality over the period 2001 to 2013 while an inverted u-shaped association between TB 
mortality and during the period 2000 to 2015 was reported by WHO (2018). Meanwhile, there 
are possible explanations for the decreasing TB death rates over time among young adults in 
South Africa. Such rapid decrease may be due to an increase in treatment success rate (83%) 
achieved in the year 2016 and reported by the National TB statistics for South Africa. The 
decline in the change rate over time represent improvements in the initiatives taken to mitigate 
the burden of TB mortality (Karim et.al 2009, World Mortality Report 2011 and Groenewald 
et.al 2017).  A burden of TB mortality was noticed in the earlier cohorts compared to later 
cohorts. This may be due to the better living and health conditions of younger cohorts and 
their exposure at younger ages under these favorable circumstances (WHO 2018). This may 
also be related to advanced medical development and antibiotics usage during the 21st century. 
This study showed higher TB mortality among older birth cohorts; therefore, it is essential to 
further strengthen screening, immunization, and treatment for older cohorts at high risk. 
 
Findings from this study are comparable to the National Burden of Diseases of South Africa 
and other studies conducted to assess and quantify the misclassification and under-reporting 
of HIV/AIDS deaths in South Africa (Pillay-van Wyk et.al 2016, Birnbaum, Murray and 
Lazano 2012). Among the four AIDS-related causes identified in this study, three are 
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document as HIV/AIDS ICD-10 codes by the national burden of disease list for the South 
Africa (Pillay-Van Wyk et.al 2014) while one was confirmed by Groenewald et.al (2005). 
This study has shown higher risk of HIV-related mortality among age groups 30-32, 33-35 
and 36-38 years compared to all other age groups. The impact of HIV-related mortality among 
age group 30-34 years in South Africa is justified in a study conducted by De wet, Oluwaseyi 
and Odimegwu (2014) during 2001-2009 period. Furthermore, Herbest, Mafojane and Newell 
(2011) also suggest a huge impact of HIV-related mortality among the childbearing age (15-
49 years). Pillay-van Wyk et.al (2016) reported a downward trend in HIV/AIDS deaths from 
2007 while De Wet et.al (2014) showed that the probability of dying from HIV/AIDS 
decreased in 2007-2009, which is similar to the findings of this study. Factors like an 
introduction of antiretroviral (ARV) treatment programme at the public health sectors (WHO 
2008) and an improvement towards completeness of vital registration with less 
misclassification over time (STATSSA 2016) may have accounted for decrease in HIV/AIDS 
Mortality. This study indicated higher HIV-related mortality risk for birth cohort 1946-1949 
to 1982-1984 with even greater risk for birth cohort 1964-1966. The results in this study agree 
with the world mortality report by UN, where it is indicated that mortality risks due to 
HIV\AIDS compared to all causes of mortality rates were higher among 1950 to 1955 birth 
cohort. Furthermore, they found the highest AIDS mortality risk among 1970-1975 birth 
cohort compared to the earlier and later birth cohorts. MacLead, Majuba and Tipping (2018) 
confirmed a higher HIV/AIDS mortality among the older birth cohort of South Africa. Factors 
like time to exposure, weak immune system and lack of education may have contributed to 
greater risk of HIV-related mortality among older birth cohort (MacLead et.al 2018).  
 
4.3       Limitations of the study 
 
The findings and subsequent discussions are subject to limitations of our study. For example, 
one of the limitations of the study was that APC models do not test hypotheses about the 
effects of environmental or historical influences; instead, they organize data and provide 
useful mathematical formulae for summarizing mortality rates over time. Officially published 
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mortality data was used, which are based on underlying cause of death. Furthermore, mortality 
data are under-reported, misclassified and incomplete (Bradshaw et al. 2012), which could 
have affected and confounded the observed rates and their interpretation. Given these 
limitations, mortality estimates should be interpreted with caution.  
 
4.4       Recommendations for Further Research 
 
Misclassification of HIV/AIDS deaths and large number of ill-defined deaths is a problem in 
South Africa. Therefore, to estimates deaths rates which are reliable, it is necessary to adjust 
mortality for misclassification, ill-defined and under-reporting. This study only focused on 
the effect of age, period and cohort on TB and HIV-related mortality.  However, one can 
assess the effect of adjusting other factors such as gender, race and socio-economic factors 
and consider the HIV\TB co-infected population. Future studies will include the top 10 leading 
causes of death with a longer period and adjusting with other demographic factors. How 
mortality trends vary at the provincial level could be looked at using the other APC approach, 
for example, Bayesian approach, nonparametric bounds and the hierarchical. Age-Period-
Cohort (HAPC). This study used aggregated data for HIV and TB cause-specific mortality, 
however individual data can be used to assess the effect of age, period and birth cohort on 
mortality.  
 
4.5       Conclusions 
 
In conclusion, despite the limitations of official published mortality data, we still found a 
notable age and period effect on TB cause-specific mortality according to APC analysis, 
which were similar to the results of previous studies. However, in contrast with official report 
of South Africa, we found a different trend for HIV cause-specific deaths rates from revised 
mortality data. Age-Period-Cohort Model of HIV and TB mortality offers a more robust 
assessment of effect of age, period and birth cohort, which would not be possible using 
traditional Poisson regression model on the death counts separately. This provides more and 
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relevant useful information for effective monitoring and evaluation of public health policies 
and programmes targeting mortality reduction across age and period in South Africa.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
44 
 
REFERENCES 
  
AA, M.A. and Naing, N.N. 2012. Comparison between Negative Binomial and Poisson Death 
Rate Regression Analysis: AIDS Mortality Co-Infection Patients. IOSR Journal of 
Mathematics, 3, 34-38. 
Adair, T. and Lopez, A.D., 2018. Estimating the completeness of death registration: An 
empirical method. PloS one, 13(5), p.e0197047. 
Adeiza M.A., Abba A.A. and Okpapi J.U. 2014. HIV associated tuberculosis: A Sub-Saharan 
Africa perspective. Sub-Saharan Afr J med, 1, 1-14. 
Age-Period-Cohort Analysis available: 
https://www.mailman.columbia.edu/research/population-health-methods/age-period-cohort-
analysis#Overview [Accessed 02 February 2017]. 
Aung, Z.Z., Saw, Y.M., Saw, T.N., Oo, N., Aye, H.N.N., Aung, S., Oo, H.N., Cho, S.M., 
Khaing, M., Kariya, T. and Yamamoto, E., 2019. Survival rate and mortality risk factors 
among TB–HIV co-infected patients at an HIV-specialist hospital in Myanmar: A 12-year 
retrospective follow-up study. International Journal of Infectious Diseases, 80, pp.10-15. 
Bennett, N.G. and Horiuchi, S., 1984. Mortality estimation from registered deaths in less 
developed countries. Demography, 21(2), pp.217-233. 
Bendavid, E., Holmes, C.B., Bhattacharya, J. and Miller, G., 2012. HIV development 
assistance and adult mortality in Africa. Jama, 307(19), pp.2060-2067. 
Biset Ayalew, M., 2017. Mortality and its predictors among HIV infected patients taking 
antiretroviral treatment in ethiopia: a systematic review. AIDS research and treatment, 
2017(2017) 2017 :e5415298. 
45 
 
Bourne, D.E., Thompson, M., Brody, L.L., Cotton, M., Draper, B., Laubscher, R., Abdullah, 
M.F. and Myers, J.E., 2009. Emergence of a peak in early infant mortality due to HIV/AIDS 
in South Africa. Aids, 23(1), pp.101-106. 
Bradshaw, D., Pillay-Van Wyk, V., Laubscher, R., Nojilana, B., Groenewald, P., Nannan, N. 
and Metcalf, C., 2010. Cause of death statistics for South Africa: Challenges and possibilities 
for improvement. South African MRC Burden of Disease Research Unit. 
Bruno, G., Maule, M., Merletti, F., Novelli, G., Falorni, A., Iannilli, A., Iughetti, L., Altobelli, 
E., d'Annunzio, G., Piffer, S. and Pozzilli, P., 2010. Age-period-cohort analysis of 1990–2003 
incidence time trends of childhood diabetes in Italy: the RIDI study. Diabetes, 59(9), pp.2281-
2287. 
Calot, G. and Sardon J.P. 2004. Methodology for the calculation of Eurostat’s demographic 
indicators.Available:http://www.cedefop.europa.eu/files/Methodology_for_the_calculation_
of_Eurostats_demographic_indicators.pdf [Accessed 12 November 2018]. 
Centers for Disease Control and Prevention. Appendix A: AIDS-Defining Conditions. 
MMWR. 2008; 57(RR10):9 
Chang, Y.H., Li, C.Y., Tung, T.H., Tsai, J.J. and Lu, T.H., 2011. Age–period–cohort analysis 
of mortality from epilepsy in Taiwan, 1971–2005. Seizure, 20(3), pp.240-243 
Curtin, L.R. and Klein, R.J. 1995. Direct standardization (age-adjusted death rates) (No. 6). 
Hyattsville, MD: US Department of Health and Human Services, Public Health Service, 
Centers for Disease Control and Prevention, National Center for Health Statistics. 
Collet, D. (2015). Modelling survival data in medical research. Chapman and Hall/CRC. 
da Silva Escada, R.O., Velasque, L., Ribeiro, S.R., Cardoso, S.W., Marins, L.M.S., Grinsztejn, 
E., da Silva Lourenço, M.C., Grinsztejn, B. and Veloso, V.G., 2017. Mortality in patients with 
HIV-1 and tuberculosis co-infection in Rio de Janeiro, Brazil-associated factors and causes of 
death. BMC infectious diseases, 17(1), p.373. 
46 
 
Day, C. and Gray, A., 2014/15. Health and related indicators. South African health review, 
2015(1), pp.213-344. 
De Wet, N., Oluwaseyi, S. and Odimegwu, C., 2014. Youth mortality due to HIV/AIDS in 
South Africa, 2001–2009: An analysis of the levels of mortality using life table techniques. 
African Journal of AIDS Research, 13(1), pp.13-20. 
Dorrington R.E., Bradshaw D., Laubscher R. and Nannan N. 2018. Rapid mortality 
surveillance report 2016. Cape Town: South African Medical Research Council. 
Dorrington, R.E., Bradshaw, D. and Wegner, T., 1999. Estimates of the level and shape of 
mortality rates in South Africa around 1985 and 1990 derived by applying indirect 
demographic techniques to reported deaths. Cape Town: South African Medical Research 
Council. 
Duzan, H. and Shariff, N.S.B.M. 2015. Ridge regression for solving the multicollinearity 
problem: review of methods and models. Journal of Applied Sciences, 15(3), 392-404. 
Fazito, E., Cuchi, P., Fat, D.M., Ghys, P.D., Pereira, M.G., Vasconcelos, A.M.N. and Pascom, 
A.R.P., 2012. Identifying and quantifying misclassified and under-reported AIDS deaths in 
Brazil: a retrospective analysis from 1985 to 2009. Sex Transm Infect, 88(Suppl 2), pp.i86-
i94. 
Gaifer ZA. Risk factors for tuberculosis mortality in a tertiary care center in Oman, 2006–
2016. Int J Mycobacteriol 2017;6:356-9. 
Gao, X., Wang, Z., Kong, C., Yang, F., Wang, Y. and Tan, X., 2017. Trends of esophageal 
cancer mortality in rural China from 1989 to 2013: an age-period-cohort analysis. 
International journal of environmental research and public health, 14(3), p.218.. 
Gesesew, H., Tsehayneh, B., Massa, D., Gebremedhin, A., Kahsay, H. and Mwanri, L., 2016. 
Predictors of mortality in a cohort of tuberculosis/HIV co-infected patients in Southwest 
Ethiopia. Infectious diseases of poverty, 5(1), p.109. 
47 
 
UNAIDS. 2016. Global AIDS Response Progress Reporting (GARPR) 2016 
Groenewald, P., Nannan, N., Bourne, D., Laubscher, R. and Bradshaw, D., 2005. Identifying 
deaths from AIDS in South Africa. Aids, 19(2), pp.193-201. 
Groenewald, P. et al. 2017. Mortality trends in the City of Cape Town between 2001 and 
2013: Reducing inequities in health. South African Medical Journal, 107(12), 1091-1098. 
Herbst, A.J., Mafojane T. and Newell M. 2011. Verbal autopsy-based cause-specific mortality 
trends in rural KwaZulu-Natal, South Africa, 2000-2009. Population Health Metrics, 9, 47. 
Hill, K. and Queiroz, B., 2010. Adjusting the general growth balance method for migration. 
Revista Brasileira de Estudos de População, 27(1), pp.7-20. 
Holford, T.R. (1983). The Estimation of Age, Period and Cohort Effects for Vital Rates. 
Biometrics, 39, 311-24. 10.2307/2531004. 
Jee Y.H. and Cho S. 2016. Age-period-cohort analysis of smoking prevalence among young 
adults in Korea. Epidemiology and Health. 38:e2016010. doi:10.4178/epih.e2016010.  
Johnson, L.F., Dorrington, R.E., 2017. Thembisa version 3.2: A model for evaluating the 
impact of HIV/AIDS in South Africa. Centre for Infectious Disease Epidemiology and 
Research, University of Cape Town. Available: 
http://www.thembisa.org/content/downloadPage/Thembisa2_4 [Accessed 26 October 2018]. 
Karim, S.S.A., Churchyard, G.J., Karim, Q.A. and Lawn, S.D., 2009. HIV infection and 
tuberculosis in South Africa: an urgent need to escalate the public health response. the Lancet, 
374(9693), pp.921-933. 
Keyes K. and Li G. 2010. A Multiphase Method for Estimating Cohort Effects in Age-Period 
Contingency Table Data. Annals of Epidemiology, 20(10), 779-85. 
10.1016/j.annepidem.2010.03.006. 
48 
 
Keyes, K.M. and Miech, R., 2013. Age, period, and cohort effects in heavy episodic drinking 
in the US from 1985 to 2009. Drug and alcohol dependence, 132(1-2), pp.140-148. 
Kootbodien, T., Wilson, K., Tlotleng, N., Ntlebi, V., Made, F., Rees, D. and Naicker, N., 
2018. Tuberculosis Mortality by Occupation in South Africa, 2011–2015. International 
journal of environmental research and public health, 15(12), p.2756. 
Lee, R.D. and Carter, L.R., 1992. Modeling and forecasting US mortality. Journal of the 
American statistical association, 87(419), pp.659-671. 
Lima, M.D.S., Martins-Melo, F.R., Heukelbach, J., Alencar, C.H., Boigny, R.N. and Ramos 
Júnior, A.N., 2016. Mortality related to tuberculosis-HIV/AIDS co-infection in Brazil, 2000-
2011: epidemiological patterns and time trends. Cadernos de saúde publica, 32, p.e00026715. 
Luo, L. 2013. Assessing validity and application scope of the intrinsic estimator approach to 
the age-period-cohort problem. Demography, 50(6), 1945-1967. 
MacLeod, W., Majuba, P.P. and Tipping, B., 2018. Human immunodeficiency virus infection 
and older adults: A retrospective single-site cohort study from Johannesburg, South Africa. 
Southern African journal of HIV medicine, 19(1). 
Musenge, E., Vounatsou, P., Collinson, M., Tollman, S., & Kahn, K. (2013). The contribution 
of spatial analysis to understanding HIV/TB mortality in children: a structural equation 
modelling approach. Global health action, 6, 19266. doi:10.3402/gha.v6i0.19266 
Naing, N.N. 2000. Easy way to learn standardization: direct and indirect methods. The 
Malaysian Journal of Medical Sciences: MJMS, 7(1), 10. 
Namosha, E., Sartorius, B. and Tanser, F., 2013. Spatial clustering of all-cause and HIV-
related mortality in a rural South African population (2000–2006). PloS one, 8(7), p.e69279. 
49 
 
Ngom, P. and Clark, S. 2003. Adult mortality in the era of HIV/AIDS: Sub-Saharan Africa. 
A paper presented in a workshop on HIV/AIDS and adult mortality in developing countries, 
8-15, September 2003, New York. 
Nguyen, D.T., Jenkins, H.E. and Graviss, E.A., 2018. Prognostic score to predict mortality 
during TB treatment in TB/HIV co-infected patients. PloS one, 13(4), p.e0196022. 
Ocaña-Riola R., Mayoral-Cortés J.M. and Blanco-Reina E. 2013. Age-period-cohort effect on 
lung cancer mortality in southern Spain. Eur J Cancer Prev, 22(6), 549-57. 
Onyango, D.O., Yuen, C.M., Cain, K.P., Ngari, F., Masini, E.O. and Borgdorff, M.W., 2017. 
Reduction of HIV-associated excess mortality by antiretroviral treatment among tuberculosis 
patients in Kenya. PloS one, 12(11), p.e0188235. 
Osagie, A.M. and Adebukola, A.C. 2017. Fitting a Poisson Regression Model to Reported 
Deaths from HIV/AIDS in Nigeria. International Journal of Statistics and Actuarial Science, 
1(5), 117-121. doi: 10.11648/j.ijsas.20170105.12  
Pillay-van Wyk, V., Msemburi, W., Laubscher, R., Dorrington, R.E., Groenewald, P., Glass, 
T., Nojilana, B., Joubert, J.D., Matzopoulos, R., Prinsloo, M. and Nannan, N., 2016. Mortality 
trends and differentials in South Africa from 1997 to 2012: second National Burden of Disease 
Study. The Lancet Global Health, 4(9), pp.e642-e653. 
Pillay-Van Wyk, V.; Laubscher, R.; Msemburi, W.; Dorrington, R.E.; Groenewald, P.; Vos, 
T.; Matzopoulos, R.; Prinsloo, M.; Nojilana, B.; Nannan, N.; et al. Second South African 
National Burden of Disease Study: Data Cleaning, Validation and SA NBD List; Burden of 
Disease Research Unit: Cape Town, South Africa, 2014. 
Podlekareva, D.N., Panteleev, A.M., Grint, D., Post, F.A., Miro, J.M., Bruyand, M., Furrer, 
H., Obel, N., Girardi, E., Vasilenko, A. and Losso, M.H., 2014. Short-and long-term mortality 
and causes of death in HIV/tuberculosis patients in Europe. European respiratory journal, 
43(1), pp.166-177. 
50 
 
Podlekareva, D.N., Efsen, A.M.W., Schultze, A., Post, F.A., Skrahina, A.M., Panteleev, A., 
Furrer, H., Miller, R.F., Losso, M.H., Toibaro, J. and Miro, J.M., 2016. Tuberculosis-related 
mortality in people living with HIV in Europe and Latin America: an international cohort 
study. The lancet HIV, 3(3), pp.e120-e131. 
Queiroz, A.A.R.D., Berra, T.Z., Garcia, M.C.D.C., Popolin, M.P., Belchior, A.D.S., 
Yamamura, M., Santos, D.T.D., Arroyo, L.H. and Arcêncio, R.A., 2018. Spatial pattern and 
temporal trend of mortality due to tuberculosis. Revista latino-americana de enfermagem, 
2018;26:e2992. 
Renshaw, A.E. and Haberman, S., 2006. A cohort-based extension to the Lee–Carter model 
for mortality reduction factors. Insurance: Mathematics and economics, 38(3), pp.556-570. 
Rosenberg, P.S. and Anderson, W.F. 2011. Age-period-cohort models in cancer surveillance 
research: ready for prime time? Cancer Epidemiol Biomarkers Prev. 2011; 20:1263–1268. 
Russo S., Flender, D. and Franssica da Silva, G. 2012. Poisson Regression Models for Count 
Data: Use in the Number of Deaths in the Santo Angelo (Brazil). Journal of Basic & Applied 
Sciences, 8, 266-269. 
Sifuna, P., Otieno, L., Andagalu, B., Oyieko, J., Ogutu, B., Singoei, V., Owuoth, J., Ogwang, 
S., Cowden, J. and Otieno, W., 2018. A Spatiotemporal Analysis of HIV-Associated Mortality 
in Rural Western Kenya 2011–2015. Journal of acquired immune deficiency syndromes 
(1999), 78(5), p.483. 
Simpfendorfer, C.A., Bonfil, R. and Latour, R.J., 2005. Mortality estimation. FAO Fisheries 
Technical Paper, 474, p.127. 
Silva, R.M.A., 2013. Papers on Indirect Mortality Estimation & Analysis in Low-Resource 
Settings (Doctoral dissertation, UC Berkeley). 
 
51 
 
Statistics South Africa. Estimating completeness of adult mortality data at sub-national level, 
2014: Findings from death notification / Statistics South Africa Pretoria. Stats SA Library 
Cataloguing-in-Publication (CIP) Data. 
Statistics South Africa. Mortality and causes of death in South Africa, 2015: Findings from 
death notification / Statistics South Africa Pretoria. Stats SA Library Cataloguing-in-
Publication (CIP) Data. 
Statistics South Africa. Mortality and causes of death in South Africa, 2017: Findings from 
death notification / Statistics South Africa Pretoria. Stats SA Library Cataloguing-in-
Publication (CIP) Data. 
Takarinda, K.C., Sandy, C., Masuka, N., Hazangwe, P., Choto, R.C., Mutasa-Apollo, T., 
Nkomo, B., Sibanda, E., Mugurungi, O., Harries, A.D. and Siziba, N., 2017. Factors 
associated with mortality among patients on TB treatment in the southern region of 
Zimbabwe, 2013. Tuberculosis research and treatment, 2017. 
Tetteh-Ahinakwa, L. and Oduro, F.T. 2017. Poisson Regression Model on Infant Mortality 
Occurrence and Incidence in the Kumasi District of Ghana. International Journal of Statistics 
and Applications, 7(2), 113-116. 
United Nations, Department of Economic and Social Affairs, Population Division. 2012. 
World Mortality Report 2011 (United Nations publication). 
Wang, Z., Bao, J., Yu, C., Wang, J. and Li, C., 2015. Secular trends of breast cancer in China, 
South Korea, Japan and the United States: application of the age-period-cohort analysis. 
International journal of environmental research and public health, 12(12), pp.15409-
15418.World Health Organization ed. 2018. Global tuberculosis report 2018. World Health 
Organization. 
Xu, M. and Powers, D.A. 2016. Bayesian ridge estimation of age-period-cohort models. In 
Dynamic Demographic Analysis (pp. 337-359). Springer, Cham. 
52 
 
Yang, Y., Schulhofer-Wohl, S., Fu, W.J. and Land, K.C., 2008. The intrinsic estimator for 
age-period-cohort analysis: what it is and how to use it. American Journal of Sociology, 
113(6), pp.1697-1736. 
Yang, Y. and Land, K.C. 2008. Age-period-cohort analysis of repeated cross-section surveys: 
fixed or random effects? Sociological Methods & Research, 36(3), 297-326. 
Yang, Y., Fu, W.J. and Land, K.C. 2004. A Methodological Comparison of Age-Period-
Cohort Models: The Intrinsic Estimator and Conventional Generalized Linear Models. 
Sociological Methodology, 34, 75-110. doi:10.1111/j.0081-1750.2004.00148. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
53 
 
APPENDIX I 
  Two-way table of number of deaths that wer modelled by age-period-cohort models 
  Time Period 
  
Age 
Groups 
1997-
1999 
2000-
2002 2003-2005 
2006-
2008 
2009-
2011 
2012-
2014 2015 
Mortality 
due toTB 15-17 672 1,086 1,242 1,281 1,312 1,187 373 
 
18-20 1,923 3,193 3,872 3,465 2,953 2,326 635 
 
21-23 4,119 6,992 8,800 8,674 6,669 4,586 1,221 
 
24-26 7,121 12,781 15,666 15,602 12,639 8,480 2,154 
 
27-29 8,821 17,514 23,327 21,787 18,200 12,855 3,309 
 
30-32 9,482 19,398 27,279 27,547 20,890 15,546 4,324 
 
33-35 9,752 18,175 27,173 28,317 23,366 16,512 4,654 
 
36-38 8,677 17,217 23,639 26,736 22,650 17,013 4,522 
 
39-41 7,861 14,536 22,209 22,674 20,332 16,104 4,702 
 
42-44 6,678 12,490 18,087 21,193 17,505 14,441 4,167 
 
45-47 6,009 10,099 15,292 17,584 16,225 12,451 3,889 
 
48-50 5,294 8,881 12,070 14,466 13,520 11,700 3,191 
 
51-53 4,024 7,069 10,138 11,509 11,540 9,884 3,287 
 
54-56 3,572 5,001 8,060 9,687 9,197 8,410 2,619 
 
57-59 3,758 4,318 5,580 7,315 7,768 7,048 2,242 
 
60-62 2,827 4,085 4,309 5,127 6,259 6,070 2,001 
 
63-64 1,526 1,980 2,796 2,913 3,025 3,431 1,101 
         
Mortality 
due to HIV 15-17 547 951 1,115 1,118 1,064 845 216 
 
18-20 1,427 2,679 3,296 2,954 2,341 1,598 404 
 
21-23 2,917 5,625 7,276 7,213 5,128 2,925 720 
 
24-26 4,966 10,224 12,861 12,734 9,447 5,244 1,178 
 
27-29 6,229 14,090 19,075 17,848 13,576 7,882 1,715 
 
30-32 6,674 15,592 22,335 22,512 15,513 9,310 2,256 
 
33-35 7,067 14,686 22,345 23,183 17,345 10,002 2,449 
 
36-38 6,451 14,118 19,517 22,057 16,897 10,297 2,406 
 
39-41 6,034 12,036 18,537 18,852 15,527 10,061 2,562 
 
42-44 5,326 10,573 15,251 17,726 13,323 9,035 2,330 
 
45-47 4,935 8,724 13,096 14,937 12,677 8,068 2,283 
 
48-50 4,525 7,823 10,560 12,463 10,696 7,828 1,850 
 
51-53 3,545 6,315 9,029 10,124 9,330 6,901 2,052 
 
54-56 3,231 4,577 7,286 8,590 7,597 5,994 1,696 
54 
 
 
57-59 3,494 4,038 5,112 6,637 6,548 5,277 1,539 
 
60-62 2,674 3,880 4,038 4,715 5,394 4,649 1,451 
 
63-64 1,454 1,903 2,675 2,711 2,697 2,695 805 
Populations 
        
 
15-17 8505345 9140314 9625088 9565414 9088974 8547570 2769263 
 
18-20 7,856,078 8,442,573 9,216,711 9,619,084 9,530,812 9,083,351 2,909,211 
 
21-23 7,020,790 7,544,929 8,458,570 9,293,025 9,731,003 9,597,122 3,113,392 
 
24-26 6,541,068 7,029,393 7,567,258 8,437,211 9,349,416 9,756,526 3,278,991 
 
27-29 6,128,401 6,585,922 6,862,404 7,553,212 8,563,231 9,427,061 3,291,478 
 
30-32 5,737,708 6,166,060 6,571,654 6,889,570 7,397,208 8,486,409 3,078,434 
 
33-35 5,370,592 5,771,535 6,087,349 6,266,258 6,626,480 7,457,888 2,704,563 
 
36-38 5,003,300 5,376,822 5,525,614 5,714,209 6,111,948 6,466,291 2,274,393 
 
39-41 4,597,070 4,940,266 5,148,025 5,255,319 5,442,051 5,821,785 2,059,244 
 
42-44 4,184,274 4,496,651 4,755,770 4,840,350 4,913,999 5,278,585 1,863,918 
 
45-47 3,775,625 4,057,499 4,291,788 4,444,793 4,606,729 4,765,128 1,636,837 
 
48-50 3,336,297 3,585,369 3,829,345 4,024,392 4,213,928 4,364,166 1,492,451 
 
51-53 2,887,112 3,102,650 3,364,333 3,583,194 3,772,769 4,012,266 1,388,761 
 
54-56 2,430,940 2,612,424 2,874,918 3,135,948 3,364,192 3,591,582 1,245,196 
 
57-59 2,053,131 2,206,408 2,425,609 2,681,565 2,935,742 3,160,310 1,101,274 
 
60-62 1,800,295 1,934,696 2,044,636 2,221,614 2,478,536 2,729,426 962,685 
  63-64 1,062,573 1,141,897 1,195,863 1,276,425 1,409,515 1,568,052 559,117 
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APPENDIX II 
Estimates of the fitted models using APC 
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APPENDIX III 
Age-period-cohort estimates for TB cause-specific mortality 
 
Constrained by period and birth cohort 
 
 
TB Cause-Specific 
Mortality IR IR
Age
15 - 17 1.00 - - 1.00 - -
18 - 20 2.59 2.51 2.67 2.52 2.44 2.60
21 -23 5.51 5.33 5.69 5.21 5.05 5.37
24 - 26 9.61 9.27 9.96 8.85 8.56 9.14
27 - 29 13.60 13.07 14.14 12.17 11.74 12.62
30 - 32 16.33 15.63 17.05 14.22 13.66 14.81
33 - 35 17.97 17.12 18.85 15.22 14.55 15.93
36 - 38 18.81 17.84 19.84 15.51 14.74 16.31
39 - 41 19.49 18.39 20.66 15.62 14.77 16.53
42 - 44 19.90 18.67 21.20 15.52 14.58 16.51
45 - 47 20.61 19.23 22.08 15.63 14.60 16.73
48 - 50 21.22 19.69 22.87 15.66 14.54 16.86
51 - 53 22.10 20.39 23.95 15.86 14.64 17.19
54 - 56 22.77 20.89 24.82 15.90 14.58 17.34
57 - 59 23.66 21.58 25.94 16.07 14.65 17.63
60 - 62 23.45 21.26 25.88 15.50 14.04 17.10
63 -64 28.36 25.53 31.50 18.23 16.41 20.25
Period
1997 - 1999 1.00 - - 1.00 - -
2000 - 2002 1.75 1.73 1.77 1.79 1.77 1.82
2003 - 2005 2.26 2.22 2.30 2.39 2.35 2.43
2006 - 2008 2.26 2.22 2.30 2.46 2.40 2.51
2009 - 2011 1.68 1.64 1.73 1.88 1.83 1.93
2012 - 2014 1.03 1.00 1.07 1.18 1.14 1.23
2015 1.14 1.10 1.19 1.35 1.30 1.41
Cohort 
1934 - 1936 1.00 - - 1.00 - -
1937 - 1939 0.79 0.74 0.84 0.77 0.72 0.82
1940 - 1942 0.78 0.73 0.82 0.73 0.69 0.78
1943 - 1945 0.63 0.59 0.66 0.58 0.54 0.61
1946 - 1948 0.59 0.56 0.63 0.53 0.50 0.56
1949 - 1951 0.73 0.68 0.77 0.63 0.59 0.67
1952 - 1954 0.80 0.74 0.85 0.67 0.63 0.72
1955 - 1957 0.83 0.77 0.89 0.68 0.64 0.74
1958 - 1960 0.92 0.86 1.00 0.74 0.69 0.80
1961 - 1963 0.99 0.92 1.07 0.77 0.71 0.84
1964 - 1966 1.11 1.02 1.21 0.84 0.77 0.92
1967 - 1969 1.11 1.02 1.21 0.82 0.75 0.90
1970 - 1972 1.21 1.10 1.33 0.87 0.79 0.96
1973 - 1975 1.23 1.11 1.36 0.86 0.77 0.95
1976 - 1978 1.20 1.08 1.33 0.81 0.73 0.91
1979 - 1981 1.05 0.94 1.17 0.70 0.62 0.78
1982 - 1984 0.94 0.84 1.06 0.61 0.54 0.68
1985 - 1987 0.85 0.75 0.95 0.53 0.47 0.60
1988 - 1990 0.75 0.66 0.85 0.45 0.40 0.52
1991 - 1993 0.75 0.65 0.85 0.44 0.38 0.51
1994 -1996 0.89 0.77 1.02 0.51 0.44 0.59
1997 - 1999 1.18 1.02 1.38 0.66 0.57 0.78
2000 1.41 1.16 1.73 0.77 0.72 0.82
Constrained Generalised Linear Model
Period 2003-2005 = 2006-2008 Cohort 1937-1938=2000
95% CI 95% CI
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Age-period-cohort estimates for HIV cause-specific mortality 
Constrained by period and birth cohort 
 
 
 
 
HIV Cause-Specific 
Mortality IR IR
Age
15 - 17 1.00 - - 1.00 - -
18 - 20 3.04 2.84 3.26 2.71 2.54 2.90
21 -23 7.59 7.06 8.16 6.04 5.66 6.43
24 - 26 14.15 13.08 15.30 10.03 9.41 10.69
27 - 29 19.85 18.19 21.66 12.55 11.74 13.41
30 - 32 24.20 21.97 26.67 13.64 12.71 14.64
33 - 35 26.15 23.47 29.13 13.14 12.18 14.17
36 - 38 26.80 23.78 30.20 12.00 11.06 13.03
39 - 41 26.46 23.19 30.18 10.57 9.66 11.55
42 - 44 26.62 23.05 30.75 9.48 8.60 10.45
45 - 47 26.02 22.24 30.45 8.26 7.44 9.18
48 - 50 25.89 21.84 30.70 7.33 6.54 8.21
51 - 53 25.78 21.46 30.99 6.51 5.76 7.36
54 - 56 26.27 21.56 32.00 5.91 5.18 6.74
57 - 59 26.38 21.36 32.59 5.29 4.60 6.10
60 - 62 27.46 21.91 34.42 4.91 4.24 5.70
63 -64 31.71 24.89 40.41 5.06 4.31 5.94
Period
1997 - 1999 1.00 - - 1.00 - -
2000 - 2002 1.12 1.09 1.14 1.25 1.23 1.28
2003 - 2005 1.33 1.28 1.38 1.67 1.63 1.72
2006 - 2008 1.33 1.28 1.38 1.88 1.81 1.94
2009 - 2011 1.52 1.43 1.61 2.40 2.30 2.51
2012 - 2014 1.71 1.59 1.84 3.04 2.88 3.20
2015 2.54 2.33 2.77 5.05 4.75 5.38
Cohort 
1934 - 1936 1.00 - - 1.00 - -
1937 - 1939 0.94 0.72 1.23 0.84 0.64 1.10
1940 - 1942 1.25 0.97 1.61 0.99 0.78 1.28
1943 - 1945 1.43 1.11 1.82 1.01 0.79 1.29
1946 - 1948 1.71 1.34 2.19 1.08 0.85 1.38
1949 - 1951 2.55 1.99 3.27 1.44 1.13 1.83
1952 - 1954 3.23 2.51 4.16 1.62 1.27 2.07
1955 - 1957 3.69 2.85 4.78 1.66 1.29 2.12
1958 - 1960 4.60 3.53 5.98 1.84 1.43 2.36
1961 - 1963 5.28 4.03 6.92 1.88 1.46 2.42
1964 - 1966 6.18 4.68 8.15 1.96 1.52 2.54
1967 - 1969 6.46 4.86 8.59 1.83 1.41 2.37
1970 - 1972 7.00 5.22 9.39 1.77 1.36 2.30
1973 - 1975 7.23 5.35 9.77 1.63 1.24 2.13
1976 - 1978 7.14 5.24 9.74 1.43 1.09 1.89
1979 - 1981 6.19 4.50 8.53 1.11 0.84 1.47
1982 - 1984 5.58 4.02 7.76 0.89 0.67 1.19
1985 - 1987 4.91 3.49 6.89 0.70 0.52 0.93
1988 - 1990 4.28 3.02 6.07 0.54 0.40 0.73
1991 - 1993 4.09 2.85 5.88 0.46 0.34 0.63
1994 -1996 4.56 3.13 6.63 0.46 0.34 0.63
1997 - 1999 6.04 4.07 8.94 0.54 0.39 0.75
2000 10.45 6.81 16.04 0.84 0.64 1.10
Period: 2003-2005 = 2006-2008 Cohort: 1937-1938 = 2000
95% CI 95% CI
Constrained Generalised Linear Model
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APPENDIX IV 
Project code 
 
//**intrinsic Estimator 
//**TB cause-specific 
apc_ie deaths if cause==1, age( age) period(period) cohort( Coh ) family(poisson) link(log) 
exposure( population) eform 
//**HIV cause-specific 
apc_ie deaths if cause==2, age( age) period(period) cohort( Coh ) family(poisson) link(log) 
exposure( population) eform 
 
//Constrained GLIM 
//**TB cause-specific// 
apc_cglim deaths if cause==1,age(age) period( period ) cohort( Coh )agepfx("_A") 
periodpfx("_P") cohortpfx("_C")family(poisson) link(log) exposure( population ) 
constraint("p2003=p2006")eform 
drop _A* _P* _C* 
apc_cglim deaths if cause==1,age(age) period( period ) cohort( Coh )agepfx("_A") 
periodpfx("_P") cohortpfx("_C")family(poisson) link(log) exposure( population ) 
constraint("a63=a15")eform 
drop _A* _P* _C* 
apc_cglim deaths if cause==1,age(age) period( period ) cohort( Coh )agepfx("_A") 
periodpfx("_P") cohortpfx("_C")family(poisson) link(log) exposure( population ) 
constraint("c2000=c1934")eform 
drop _A* _P* _C* 
 
//**HIV cause-specific// 
apc_cglim deaths if cause==2,age(age) period( period ) cohort( Coh )agepfx("_A") 
periodpfx("_P") cohortpfx("_C")family(poisson) link(log) exposure( population ) 
constraint("p2003=p2006")eform 
drop _A* _P* _C* 
apc_cglim deaths if cause==2,age(age) period( period ) cohort( Coh )agepfx("_A") 
periodpfx("_P") cohortpfx("_C")family(poisson) link(log) exposure( population ) 
constraint("a63=a15")eform 
drop _A* _P* _C* 
apc_cglim deaths if cause==2,age(age) period( period ) cohort( Coh )agepfx("_A") 
periodpfx("_P") cohortpfx("_C")family(poisson) link(log) exposure( population ) 
constraint("c2000=c1934")eform 
